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ABSTRACT 
Osteopontin (OPN) is a multifunctional protein presented in various organs and 
body fluids in human body. OPN serves important roles in bone remolding, wound 
healing, and other biomineralization related physiological activities, which gives it great 
potential health benefits. Clinical statistics and laboratory researches also indicate that 
OPN can be a suitable diagnostic and prognostic marker for cancer progression. Its role 
in cell signaling remains one of the hot topics in biomedicine research. However, there 
was no efficient and scalable process for OPN purification from recombinant sources 
reported, which prevents OPN unleashing its full potential in health industry. Low 
expression level, acidic isoelectric point, and the lack of well-defined secondary and 
tertiary structure are some of the challenges that faced purification development of OPN 
from Escherichia coli (E. coli) lysates. Finding an adequate capture step with sufficient 
specificity and binding capacity that could be paired with an orthogonal purification step 
was a vitally important objective for this project. 
In recent years, mixed-modal chromatography (MMC) resins have opened up 
new possibilities for protein purification. The combination of high-throughput screening 
(HTS) platforms and design of experiment (DOE) principles could accelerate process 
development exponentially. 
In this research, seven chromatography resins including traditional ion exchange 
resin, hydrophobic interaction resin and 5 mixed-modal resins were screened for OPN 
purification. Plate based HTS was applied and quickly revealed comprehensive 
information about the affinity between the ligands and the target protein, specificity of 
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the adsorption, and the binding capacity of the resins. Based on HTS results, the 
bind/elute processes for all candidate resins were designed, tested and optimized with 
small scale batch adsorption experiments. The purification factors and OPN recoveries 
achieved by batch adsorption experiments were verified on packed-bed columns 
operated by ÄKTA system and analyzed statistically. In terms of purification factor and 
yield, HEA HyperCel and Capto Q performed significantly better than the rest of the 
candidate resins. Two 2-step purification processes assembled with these two resins 
elevated OPN purity from 2% from the lysate to over 95% purity with greater than 40% 
yield. 
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NOMENCLATURE 
AS Ammonia Sulfate 
BSA Bovine serum albumin 
CV Column volume 
DBC Dynamic binding capacity 
E. coli Escherichia coli 
ELISA Enzyme-linked immunosorbent assay 
FPLC Fast protein liquid chromatography 
HCP Host cell protein 
HIC Hydrophobic interaction chromatography 
HRP Horseradish peroxidase enzyme 
HTS High-throughput screening 
IEX Ion exchange chromatography 
MMC Mixed-modal chromatography 
MWCO Molecular weight cut-off 
NaCl Sodium Chloride 
NaP Sodium phosphate 
OPN Osteopontin 
PBS Phosphate-buffered saline 
PES Polyethersulfone 
pI Isoelectric point 
PMSF Phenylmethane sulfonyl fluoride 
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PTM Post-translational modification 
REML Residual maximum likelihood 
RO Reverse osmosis 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
TMB 3,3′,5,5′-Tetramethylbenzidine 
TP Total protein 
Tris Tris (hydroxymethyl) aminomethane 
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1 INTRODUCTION AND LITERATURE REVIEW 
1.1 Introduction 
Osteopontin (OPN) is a protein essential for bone remodeling, wound healing, 
and inhibition of kidney stone formation. It also plays important roles in cell signaling 
pathways and cell migration activities in regular conditions and stress responses, which 
makes OPN a suitable molecular marker for cancer cell types and cancer progression. 
The potential health benefits as well as potential diagnostic and prognostic value of OPN 
have invigorated the search for an efficient and scalable purification process. Although 
OPN was identified and isolated in the 1980s1-3, there has not been a feasible process 
reported for large scale OPN production. Ion exchange and hydrophobic interaction 
chromatography methods have been used for OPN purification from native and 
recombinant sources, however, most of the reported purification processes suffered from 
low yield and poor scale-up capabilities4-5. The lack of efficient OPN purification 
strategies for large scale production hindered OPN from unleashing its full potential in 
the health industry. 
As new technologies for downstream processing are being developed, it is time 
to revisit the challenge of OPN purification. Recently, mixed-modal chromatography 
(MMC) resins have caught attention for their wide range of adsorption chemistries and 
unique features compared to traditional single mode resins. And 96-well plate based 
high-throughput screening technologies (HTS) combining with statistics can 
exponentially accelerate resin-protein interaction studies, resin screening and process 
optimization. 
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In this project, high-throughput process development strategy was implemented 
to the design of a robust, efficient, and scalable OPN purification process. 
1.2 Literature review 
1.2.1 Osteopontin(OPN) properties and roles in body fluids 
OPN is a multifunctional protein present in a wide variety of mammalian organs 
and tissues. Studies on its physical and chemical properties and functions in various 
biochemistry processes are being reported on a regular basis. 
OPN is single polypeptide composed of about 300 amino acids. The backbone 
molecular weight is 33 kDa. However the apparent molecular weight can range from 45 
kDa to 75 kDa when analyzed by SDS-PAGE due to the posttranslational modification 
and its high negative charge6. OPN is highly acidic with an isoelectric point at about 
4.31. OPN is often categorized as a Intrinsically Disordered Protein (IDP) which is 
biologically active in an flexible form lacking a well-defined secondary and tertiary 
structure7-8. As shown in Figure 1, OPN has a polyaspartic acids motif which serves as 
calcium binding sites and an arginine-glycine-aspartic acid (RGD) domain that binds to 
integrins and promotes cell migration and adhesion activities. 
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Figure 1  Model of human OPN (Reprint from Kazanecki et al. 20079) 
 
OPN undergoes extensive posttranslational modification (PTM) events in the 
bone and other tissues. Bovine mammary gland OPN has 3 O-glycosylation and 28 
phosphorylation sites10. Human milk OPN has 5 O-glycosylation and 29 phosphorylation 
sites11. Phosphorylations on OPN often appear in clusters and the extent of 
phosphorylation varies with the issue OPN was expressed in. OPN serves various 
functions which will be discussed in the following sections. 
OPN is highly expressed in the bone. Its function in bone formation and 
calcification was first discovered in 198912. OPN is highly enriched in the mineralization 
front anchoring Osteoclasts to the mineral matrix of bones13. Later research revealed that 
OPN acts as a mediator of cell-matrix and matrix-matrix adhesion in the formation and 
repair process of regular or pathological mineralized tissues14. The calcium binding sites 
allows OPN tightly binds to hydroxyapatite— the major inorganic component of bone 
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matrix. The RGD domain in the middle of OPN sequence provides an integrin binding 
site which living cells attach to and facilitate their mobility15. OPN knock-out mice 
model helped researchers uncovered the importance of OPN in bone development as 
OPN knock-out mice developed hyper-mineralized bones and suffer from high fragility 
and deficiency of stress-induced bone remodeling16. 
The biomineralization function of OPN does not stop within the bone. OPN plays 
an important role in the inhibition of renal stones which are mostly composed of calcium 
salts. Urine is often supersaturated with respect to calcium oxalate but most people do 
not form stones. OPN is one of the many biological macromolecules that prohibit the 
aggregation of calcium oxalate thus preventing the nucleation and growth of renal 
stones. OPN is synthesized and secreted in the kidney by epithelial cells17-18. 
Experiments both in vitro and in vivo show direct evidence that OPN inhibit calcium 
crystal formation19-20. OPN can be found in urine with concentration ranging from 1.9 to 
4.3 µg/ml. The lower limit of OPN sufficient for the inhibition of calcium oxalate 
aggregation is reported to be 1.9 µg/ml19. One study reported that single base mutation in 
OPN gene was identified from patients with recurrent stone formation or familial 
urolithiasis21. 
Besides its functions in biomineralization and related health benefits, OPN is also 
involved in cell signaling and cancer progression. OPN expression is significantly up-
regulated in cancer cells compared with normal tissue cells in at least 30% of cancer 
patients22. L. Shevde 23 did a good job reviewing the roles OPN plays in cancer 
progression. OPN expression level and its post-translational modification are highly 
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correlated with cancer cell types and tumor stages, so it could serve as a valuable marker 
for cancer prognosis and diagnosis24-25. 
Moreover, studies about the functionality of OPN in cell signaling and cancer 
progression are being reported on a regular basis, which makes it vitally important to 
have a robust way to produce full-length OPN free from variation introduced by post-
translational modification for related research purposes and anti-body development. 
1.2.2 Escherichia coli (E. coli) expression system and recombinant OPN 
E. coli is one of the most widely applied and well-studied expression systems for 
recombinant protein production. The first recombinant DNA was transferred to E. coli 
cells in 197326 and the FDA approved E. coli recombinant human insulin for the diabetes 
treatment which is the first recombinant pharmaceutical entering the market27-28. Since 
then, E. coli produced pharmaceuticals took off in the market and remains the major 
work horse in the biopharmaceutical industry producing 30% of approved therapeutic 
proteins in the market29. Although increasing numbers of biopharmaceuticals from 
mammalian cell lines have been approved, quantitatively speaking, microbial systems 
continues to dominate the market as 17.9 metric tons of active biopharmaceutical 
ingredient (68%) being derived from microbial systems30 with  E. coli expressed protein 
products being the major contributor. Human insulin alone contributed more than 6 
metric tons of production annually. And recombinant insulin from Ely Lilly alone 
generated revenue of $1.366 billion for the company in 2016 according to its annual 
financial report. Table 1 is a list of biopharmaceuticals from E. coli approved to enter the 
market. 
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Table 1  List of biopharmaceuticals produced in E. coli (Reprint from Beashen et 
al. 201529) 
Biologic Therapeutic Indication Year of 
Approval 
Company 
Humulin (rh 
insulin) 
Diabetes 1982 US Eli Lilly 
IntronA 
(interferon α2b) 
Cancer, hepatitis, genital 
warts 
1986 US Schering-Plough 
Roferon 
(interferon α2a) 
Leukemai 1986 US Hoffmann-La-
Roche 
Humatrope 
(somatropin rh 
growth hormone) 
hGH deficiency in children 1987 US Eli Lilly 
Neupogen 
(filgrastim) 
Neutropneia 1991 US Amgen Inc. 
Betaferon 
(interferon β-1b) 
Multiple sclerosis 1993 US Schering Ag 
Lispr (fast-acting 
insulin) 
Diabetes 1996 US Eli Lilly 
Rapilysin 
(reteplase) 
Acute myocardial infarction 1996 US Roche 
Infergen 
(interferon 
alfacon-1) 
Chronic hepatitis C 1997 US Amgen 
Glucagon Hypoglycemia 1998 US Eli Lilly 
Beromun 
(tasonermin) 
Soft sarcoma 1999 EU Boehringer 
Ingelheim 
Ontak 
(denileukin 
diftitox) 
Cutaneous T-cell lymphoma 1999 US Seragen Inc. 
Lantus (long-
acting insulin 
glargine) 
Diabetes 2000 US Aventis 
Kineret 
(anakinra) 
Rheumatoid arthritis 2001 US Amgen 
Natrecor 
(nesiritide) 
Congestive heart failure 2001 US Scios Inc. 
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Table 1 continued. 
Somavert 
(pegvisomant) 
Acromegaly 2003 US Pharmacia NV 
Calcitonin 
(recombinant 
calcitonin 
salmon) 
Post menopausal 
osteoporosis 
2005 Upsher-
Smith  Laboratories 
Lucentis 
(ranibizumab) 
Wet age-related macular 
degeneration 
2006 US Novartis 
Preotact (human 
parathyroid 
hormone) 
Osteoporosis 2006 EU Nycomed Danmark 
Krystexxal (rh 
urate oxidase, 
PEGylated) 
Gout 2010 Saviant 
Nivestim 
(filgrastim, 
rhGCSF) 
Neutropenia 2010 Hospira 
Voraxaze 
(glucarpidase) 
Lowering of toxic level of 
methotrexate concentration 
in patients with impaired 
renal function 
2012 BTG International 
Preos 
(parathyroid 
hormone) 
Osteoporosis, 
hypoparathryroidism 
2013 EU NPS 
Pharmaceuticals 
 
E. coli remains strong as one of the most desired expression systems for both 
scientific research usage and protein therapeutics manufacturing. The rapid growth of E. 
coli allows for high production rate and minimal risk of contamination. After decades of 
research and development, well-structured frameworks and toolboxes are available for 
E. coli recombinant expression, which makes new strain construction relatively easy. 
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Recombinant protein can be accumulated up to 30% of the total E. coli protein which 
gives a great starting point for extraction and purification29. 
Although E. coli expression system is usually incapable of glycosylation and 
phosphorylation due to the lack of cellular machinary31, recombinant OPN from E. coli 
made major contributions to OPN related research as multiple functions of the protein 
relies mainly on its primary structure. E. coli expressed OPN showed cell adhesion 
enhancement, cell proliferation activities32 and, cell migration improvement activities4. 
And full length bioactive OPN without variance introduced by post-translational 
modification can be a great material for research usage and antibody development. In 
vitro phosphorylation of OPN has been achieved since 199333, which makes producing 
full-length PTM free OPN an versatile option for phosphorylation related studies of 
OPN. 
1.2.3 Protein purification by chromatography 
Chromatography has been the work horse of protein purification in 
biopharmaceutical industry. The separation power provided by chromatography is 
unparalleled from other non-chromatographic methods thus essential for injectable 
biopharmaceuticals for which high purity is an absolute necessity. Chromatography 
process for biopharmaceuticals often requires high-quality chromatographic medium 
(resin) for maximum resolution, expensive pumping systems for precise flow controls 
and highly-skilled labor forces to operate them, which all contribute to the high cost of 
chromatography processes. In fact, chromatography is one of the major contributors of 
the overall cost for biopharmaceutical manufacturing and sometimes dictates the 
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financial feasibility of drug candidates. Therefore, the design and optimization of 
chromatography steps are vitally important for biopharmaceutical process development, 
which is exactly what this research is focusing on. 
Proteins adsorb to the solid phase by various kinds of physio-chemical 
interactions such as electrostatic interaction, hydrophobic interaction, and the 
combination of the two. The specific interactions and their applications are discussed in 
the following sections. 
Chromatography for protein purification often works in either one of the two 
modes—bind/elute mode and flow-through mode. For bind/elute mode, target protein 
adsorbs to the stationary phase (ligands on resins in most cases) and gets retained during 
sample loading while impurities flow through. Then by altering the conditions of the 
mobile phase, protein-resin interaction can be disrupted allowing the elution of the 
protein from the column. Multiples steps with different conditions or gradient elution 
can be used to further fractionate the molecules bound to the column for maximum 
separation. Bind/elute mode is useful for most protein purification practices especially as 
the capture step due to its ability for volume reduction. For flow-through mode, loading 
conditions need to be selected that the target protein would not be retained by the resin 
while impurities would. The target protein can be collected in the flowthrough fraction 
with the impurities removed. Flow-through mode chromatography often applied as the 
polishing step for biopharmaceuticals. For example, anion exchange resins are used to 
bind and remove negatively charged impurities such as leached protein A and DNA from 
almost charge neutral antibodies after they are captured by protein A affinity columns. 
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1.2.3.1 Ion exchange chromatography (IEX) 
Ion exchange chromatography in protein purification relies on the reversible 
electrostatic interactions between proteins in the mobile phase and the stationary phase 
of opposite charge. IEX resins are categorized as anion (negatively charged group) or 
cation (positively charged group) and can be further categorized as strong or weak. 
Resin selection usually begins with strong ion exchangers (Q or,S) for their ability to 
work in broad range of pH conditions. Weak ion exchangers should be considered when 
the selectivity provided by strong ion exchangers is unsatisfactory. 
 
Table 2  List of commonly used ion exchangers for protein purification 
Type of Ion Exchanger Common Abbreviation Functional Group 
Strong Anion Q Quandary Ammonium 
Weak Anion DEAE Diethylaminoethyl 
Strong Cation S Sulfonic Acid 
Weak Cation  CM Carboxymethyl 
 
The resin selection and adsorption condition design is highly dependent on the 
isoelectric point (pI) of the protein and the pKa of the ligand. Isoelectric point is the pH 
condition where the net charge of a protein stays neutral. Figure 2 is a visual 
representation of how protein charge varies under different pH conditions based on 
ProtCalculator simulation program. OPN has zero charge when at its pI which in this 
program is predicted to be 4.6 by the algorithm. When the pH in the solution is below 
the pI, protein takes a positive net charge. When the pH becomes higher than the pI of 
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protein, protein becomes negatively charged. Therefore, in the case of OPN, anion 
exchange sorbents could be used for OPN adsorption at pH above 5 and cation exchange 
sorbents could only be used when pH is below 4, which are the conditions used and 
reported for OPN purification4. 
 
Figure 2  Surface charge prediction of OPN, plotted from prediction generated by 
ProtCalculator v3.4 (ProtCalc.net) 
 
For ion exchange chromatography, low ionic strength conditions are often 
required for efficient adsorption and ascending salt concentration solutions can disrupt 
the electrostatic interactions between oppositely charged proteins and ligands, so often 
applied as elution buffer. 
1.2.3.2 Hydrophobic interaction chromatography (HIC) 
Hydrophobic interaction chromatography works by utilizing the reversible 
interaction between the hydrophobic patches on the protein in the solution and the 
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hydrophobic surface of the HIC resin. HIC fractionates proteins based on their 
differences in surface hydrophobicity. 
The hydrophobicity of resins varies with ligand structure, ligand density and the 
backbone structure of the resin. Figure 3 demonstrated HIC resins with different 
hydrophobicity from the same manufacturer. 
 
Figure 3  Hydrophobicity of HIC resins (Reprint from GE Healthcare 
Lifesciences34) 
 
HIC usually requires high ionic strength condition to promote hydrophobic 
interactions between protein and resin for efficient adsorption. Therefore, HIC can be 
particularly useful as a capture step after the crude extract was fractionated by salt 
precipitation or as a polishing step after ion exchange chromatography, since in both 
cases the samples are already in high salt conditions. 
However, high ionic strength conditions also promote hydrophobic interaction 
between proteins which may results in protein loss due to aggregation. Therefore, one of 
the most important parameter in HIC process development is determining the maximum 
salt concentration in which target protein remains stable in the solution. Protein elution 
can be achieved by decreasing the salt concentration in the elution buffers. 
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1.2.3.3 Mixed-modal chromatography (MMC) 
Mixed-modal chromatography sorbents have caught attention from separation 
developers in recent years for its unique features comparing to traditional single mode 
chromatography media. 
One advantage of mixed-modal chromatography is a wide variety of chemistries 
that could provide orthogonality to traditional single mode chromatography. For 
example, Capto adhere resin has been developed and commercially employed to remove 
antibody aggregates and leached protein A at the same time during monoclonal antibody 
production35. Mixed-modal sorbents have been tested as alternatives to protein A resin 
for antibody capture36-39 and capture chromatography step for recombinant proteins from 
E.coli crude extract as well40-43. In the latter case, mixed- modal adsorption exhibited 
unique advantages over single mode sorbents. 
Since this study focuses on resins with mixed ionic and hydrophobic properties, 
key chemistries and properties of mixed-modal ligands is reviewed next. Hydrocarbyl 
amines are among the popular MMC ligands as the amine group serves as the active sites 
for immobilization and the positively charged group for electrostatic interaction while 
the hydrocarbon group provides hydrophobicity to the resin (Table 3)44. Protein 
adsorption to hydrocarbyl amine based resins takes advantage of both ion exchange and 
hydrophobic properties and elutions are often achieved at low pH when electrostatic 
repulsion overcomes hydrophobic attraction. Commercialized resins HEA HyperCel and 
PPA HyperCel tested in this research belong to this category. 
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Adding phenyl groups and hydrogen bonding groups to traditional ion 
exchangers gives mixed-modal features to IEX resins. Commercialized examples for 
such resins are Capto adhere and Capto MMC which are designed this way to be mixed-
modal anion exchanger and cation exchanger respectively. 
Other type of resins that have hydrophobic and ion exchange properties are 
designed so that the charge on the ligand varies with the change of pH in the solution. 
Chromatographic separations with these types of resins are referred to as hydrophobic 
charge induction chromatography (HCIC). 4-Mercaptoethylpyridine (MEP) resin with a 
pKa of 4.85 is an example of hydrophobic charge induction chemistry (Table 3). At pH 
above 4.85, the ligand remains neutral charge and binds protein via hydrophobic 
interactions.  When the pH of the solution drops below ligand pKa and protein pI, the 
protein is rejected due to electrostatic repulsion. 
As described in the previous sections, IEX adsorption often requires low 
conductivity but HIC adsorption for proteins usually needs high ionic strength 
conditions. The conflicting ionic strength requirements underscore the fundamental 
features of mixed-modal resins, which makes optimal conditions for protein adsorption 
hard to predict. This is why high-throughput screening (HTS) is helpful allowing testing 
wide range of pH and conductivity conditions in parallel for comprehensive 
understanding of protein and mixed-modal interactions42, 45-46. Because specific 
interactions of both the target protein and host cell proteins (HCPs) with a selected resin 
dictates the separation efficiency, HTS technology becomes a particularly helpful tool 
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for identifying optimal pH and ionic strength conditions i.e. “the sweet spot” for target 
protein purification. 
Table 3  List of mixed-modal chromatography resins (Reprint from Zhao et al. 
200947) 
 Name Structure pKa 
Ligands 
with positive 
charge 
Alkylamine  
, n = 1–5, 
6, 8 
≈10 
α,ω-Diamino alkane  
, n = 2–6, 8, 
10 
≈10 
Phenylalkylamine  
, n = 1, 
3, 4 
6–7 
2-Amino-1-phenyl-1,3-
propanediol  
 
9.0 
N-Benzyl-N-methyl ethanol 
aminec 
 
– 
4-Mercaptoethylpyridine 
 
4.85 
2-Aminomethylpyridine 
 
pKa1 = 2.2, 
pKa2 = 8.5 
Mercaptomethylimidazole 
 
5.3 
2-Mercaptobenzimidazole  
 
4.1  
Tryptamine  
 
10.3 
5-Aminoindole 
 
3.9 
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Table 3 continued. 
Ligands 
with 
negative 
charge 
Aminoalkyl carboxyl 
acid , n = 5, 9 
5.2  
N-(3-
Carboxypropionyl) 
aminodecyl amine 
 
9.1  
N-pyromellityl 
aminodecyl amine 
 
pKa1 = 2.2,
 
pKa2 = 3.4,
 
pKa3 = 5.4, 
2-Benzamido-4-
mercaptobutanoic acid 
 
3.3 
2-Mercapto-5-
benzimidazole 
sulfonic acid 
 
– 
6-Amino-4-hydroxy-2-
naphtalene sulfonic 
acid  
 
– 
2,5-Dimercapto-1,3,4-
thiadiazole 
 
6.3 
 
1.2.4 OPN purification methods 
Different approaches to produce purified OPN for biochemistry studies have 
been reported. Milk is one of the most used source to recover OPN. Anion exchange 
chromatography has been the default capture step for OPN recovery since the 19893. 
In addition to precipitation steps for lipids and casein removal, multiple 
chromatography steps are often applied to purify OPN from milk. Bayless and 
colleagues used weak ion exchanger DEAE to capture OPN from skim milk. It took 
them two additional HIC steps to obtain purified OPN. Both HIC steps involved Phenyl-
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Sepharose resin and 2 M NaCl as the elution condition. The only difference between the 
two consecutive HIC steps was the binding conditions which were 4 M and 5 M NaCl 
respectively. The first HIC step could only elevate purity to 35% and the purity finally 
reached close to 100% after the second HIC5. The use of similar steps in series is never 
ideal in terms of economic feasibility. Sørensen et al. went for direct capture by anion 
exchange chromatography from milk before casein removal. Hydroxyapatite 
chromatography with sodium phosphate elution and negative affinity chromatography 
were added to the process to purify OPN from other milk protein48. However, the 
negative affinity chromatography used in this process is not applicable for large scale 
production. Azuma et al. used DEAE based anion exchange chromatography at pH 5 
taking advantage of the low pI of OPN to purify OPN from milk to 85% in one step. 
Another anion exchange chromatography step was used to remove residual milk protein 
to obtain purified OPN in the process49. However, none of the processes reported overall 
yield due to the fact that the concentration of OPN in raw milk were below their 
detection limits. Moreover, molecular weight variation due to different degree of 
modification was observed from OPN purified from milk. 
Various strategies have been applied to purify OPN from recombinant E. coli. 
Fusion tags were widely used for OPN biochemistry researches since the early days for 
its convenience in purification. Glutathione S-transferase (GST) affinity chromatography 
was among the most popular for OPN and yielded highly purified OPN in a single step 
due to the high specificity provided by strong affinity between GST and glutathione.50-51 
His-tag was also used in the construct of recombinant OPN in E. coli.32 However, these 
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methods were used to produce micrograms of purified OPN for biochemistry studies 
without supporting evidence of yield and potential scalability. Large tags such as GST 
require removal steps which add expenses. Since there is a thrombin cleavage site near 
the RGD domain in the OPN sequence, thrombin would destroy the RGD-mediated 
adhesion activities of OPN. Thrombin cleavage being a popular method for large tag 
removal is not an option used in full-length OPN production, which adds difficulties in 
using tags for OPN purification51. In general, tagged proteins are not desirable for 
injectable therapeutics. 
Non-tag methods for OPN purification from recombinant E. coli were also 
reported. Based on OPN’s calcium binding nature, hydroxyapatite chromatography was 
used as the single chromatography step to purify OPN from E. coli lysate. The feed of 
hydroxyapatite chromatography was fractionated by ammonium sulfate precipitation and 
recovered from 20% to 40% ammonium sulfate precipitates. However, this process was 
done at the microgram scale and no evidence of purity nor recovery was reported52. A 
series of precipitation steps (isoelectric precipitation steps at pH 6, 5, 4.3 and the 
supernatant was precipitated by 20% saturation ammonium sulfate and then re-
solubilized) achieved 45% OPN purity from 7% purity E. coli lysate, while yield 
dropped to 21% during the precipitation steps. A final purity of 97% was achieved by 
additional two ion exchange chromatography steps with conditioning steps in between. 
The overall yield was as low as 12.8%4. In general usage of multiple precipitation and 
non-orthogonal processes in series are not ideal in downstream processing, yet there are 
no other strategies that have higher efficiency for OPN recovery to date. The lack of 
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high yield and high efficiency strategies for OPN production hindered related research 
from moving on to larger scale. 
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2 MATERIALS AND METHODS  
2.1 E. coli cell cultivation and harvest 
The OPN recombinant E. coli strain is provided by collaborator from University 
of California, San Diego. The construct was based on BL21-AI strain. The production of 
recombinant OPN was regulated by arabinose inducible promotor. A FLAG fusion tag 
was added to the N-terminus of recombinant OPN for detection and identification. The 
strain construct contains an ampicillin resistance selective marker. 
The strain was kept as frozen stock cell bank in 25% glycerol at -80°C for long 
term storage. 
To start new culture, 1 mL of frozen stock cell was inoculated in 25 ml Miller’s 
Luria Broth (LB medium, Miller’s) (Sigma-Aldrich, L3522) with 150 µg/ml ampicillin 
(Sigma-Aldrich, A1593) and incubated at 37°C on an orbital shaker at 200 rpm for 5 
hours. 5 ml of seed culture was transferred to 500 ml Terrific Broth (Sigma-Aldrich, 
T0918) with 50 µg/ml ampicillin and incubated at 37°C and 200 rpm shaking until OD 
600 reached 0.8. The recombinant protein production was induced by adding arabinose 
(Sigma-Aldrich, A3256) to a final concentration of 0.2% (w/v). And the cells were 
incubated at 37°C with 200 rpm mixing overnight. The cells were harvested by 
centrifugation at 3,000 g for 10 minutes at 4°C. The harvested cell biomass was kept in -
80°C until use. 
2.2 Cell lysis and protein extraction 
The frozen biomass was suspended in lysis buffer (50 mM Tris, 150 mM NaCl, 1 
mM PMSF, pH 7.4) at 1:10 (w/v) ratio in room temperature. The suspended cells then 
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were lysed by sonication (QSonica, Q55) with 30 seconds on and 30 seconds off cycle 
on an ice bath for 5 cycles at 40% amplitude. The cell debris was removed by 
centrifugation at 15,000 g for 30 minutes at 4°C. The supernatant was collected and 
filtered with a 0.22 µm syringe filter (PES membrane, Olympus plastics) to produce 
clarified cell lysate, which was the starting material for all experiments discussed in this 
thesis. 
2.3 High-throughput screening (HTS) of mixed-modal sorbents 
HTS experiments were performed to study the interaction between OPN and 
various mixed-modal ligands at varying NaCl and pH conditions. Salt concentration and 
pH were tested at multiple levels using full factorial design experiments with 3 
replicates. A 3x3 full factorial design (pH 5, 7, 9 and NaCl concentration 0, 1.5, 3 M) 
was performed for HEA HyperCel and PPA HyperCel resins. For Capto adhere, 4x3 full 
factorial design (pH 5, 6, 7, 8 and NaCl concentration 0, 0.4, 0.8 M) was used. The pH 
of cell lysate was adjusted with 0.2 M HCl or 0.2 M NaOH. The salt concentration was 
adjusted by adding solid NaCl to the cell lysates to the designed concentration or by 
dialysis when salt removal was required. The pH and/or salt adjustment was followed by 
end-over-end mixing for 15 minutes and clarification by centrifugation at 15,000 g for 
30 minutes at 4°C to remove any protein precipitates that might have formed during 
condition adjustment. The resulting samples were referred to as conditioned lysate and 
served as starting feed for HTS experiments. 
Adsorption experiments were carried out by dispensing 0.05 mL of resin 
(supplied as 50% slurry) in a 96-well filter plate (3M Empore).  The resin storage buffer 
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was removed by centrifugation at 300 g for 7 minutes at 4°C. Resin equilibration was 
achieved by adding 0.2 mL (4 resin column volumes) of prescribed loading buffer to 
each resin in the wells. The resin and loading buffer in the wells were mixed gently for 
10 minutes. After that the buffer was removed by centrifugation at 300 g for 7 minutes. 
The resin equilibration process was repeated twice. Conditioned lysate (0.2 mL of lysate 
for each well) was then added to the equilibrated resin and incubated with gentle mixing 
for 1 hour at room temperature. The unbound sample was collected by centrifugation 
(300 g, 7 minutes, 4°C) for analysis. Total protein of the samples was measured by 
Bradford assay and OPN concentration by ELISA. The procedure was repeated for each 
of the tested resins, HEA HyperCel, PPA HyperCel and Capto adhere. 
2.4 Batch adsorption and elution of OPN 
Batch adsorption experiments followed by gravity-flow elution were used as a 
scale-down model for optimizing bind/elute conditions and resin performance 
evaluation. The chromatography adsorbents (resins) screened in this study included 
strong anion exchanger Capto Q, traditional hydrophobic interaction resin Phenyl 
Sepharose (6 Fast Flow, high sub), and 5 mixed-modal sorbents— HEA HyperCel, PPA 
HyperCel, MEP HyperCel, Capto adhere, and ceramic hydroxyapatite (CHT). 
Capto Q, Phenyl Sepharose and Capto adhere were purchased from GE 
Healthcare, HEA, PPA and MEP HyperCel from Pall, and Ceramic Hydroxyapatite from 
Bio-Rad. The ligand structure and primary adsorption chemistry are listed in Table 4. 
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Table 4  List of candidate chromatography sorbents for OPN purification. 
Adsobent 
(Resin) 
Vendor Adsorption 
chemistry 
Ligand structure Matrix 
HEA 
HyperCel 
Pall Hydrophobic 
interaction; 
Electrostatic 
interaction 
Hexylamine 
 
Cellulose 
PPA HyperCel Pall Hydrophobic 
interaction; 
Electrostatic 
interaction 
Phenylpropylamine 
 
Cellulose 
MEP 
HyperCel 
Pall Hydrophobic 
interaction 
4-Mercaptoethylpyridine 
 
Cellulose 
Capto adhere GE Electrostatic 
interaction; 
Hydrophobic 
Interaction 
 
N-benzyl-n-methyl 
ethanolamine
 
Agarose 
matrix 
with 
dextran 
surface 
extender 
Ceramic 
hydroxyapatite 
Bio-
Rad 
Calcium 
affinity; 
Electrostatic 
interaction 
(Ca5(PO4)3OH)2 matrix serves as both 
backbone and ligand 
Capto Q GE Electrostatic 
interaction 
Quaternary amine 
 
Agarose 
matrix 
with 
dextran 
surface 
extender 
Phenyl 
Sepharose (6 
Fast Flow, 
high sub) 
GE Hydrophobic 
interaction 
Phenyl Spherical 
6% cross-
linked 
agarose 
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The general batch adsorption experiment procedure with all candidate resins was 
as follows: Conditioned cell lysates were incubated with pre-equilibrated sorbents for 1 
hour with end-over-end mixing at room temperature. The loading volume was set at 6 
column volumes (1.2 ml conditioned lysate load to 0.2 ml resin) for all the resins tested, 
equivalent to feeding about 30 mg total protein/ml resin. The lysate-resin mixture was 
then loaded on a PolyPrep column (Bio-Rad) and the unbound protein after equilibrium 
binding would pass through and be collected by gravity as “Flowthough”. The resin was 
washed with 10 column volumes of loading buffer. Adsorbed proteins were eluted using 
10 column volumes of appropriate elution buffer. All the samples were collected by 
gravity for analysis. The average gravity-driven linear velocity during elution was about 
100 cm/h. The specific protocols designed for individual resins are listed below: 
Capto Q batch adsorption and elution. The clarified lysate was conditioned by 
dialysis against 50 mM Tris buffer (pH 7) overnight at 4°C for salt removal using 
SnakeSkin dialysis tubing (MWCO = 3.5 kDa, ThermoFisher Scientific). The 
conditioned lysate was incubated with Capto Q resin for 1 hour at room temperature by 
end-over-end mixing. The lysate-resin mixture was then transferred to PolyPrep column 
(Bio-Rad) and the “flowthrough” sample was collected by gravity. The resin was washed 
by 20 column volume of 50 mM Tris pH 7 binding buffer. The elution was achieved in 3 
stages: 0.2 M NaCl, 0.5 M NaCl, and 1 M NaCl. All elution buffers were buffered by 50 
mM Tris at pH 7. 
Phenyl Sepharose batch adsorption and elution. The clarified lysate was 
conditioned by adding solid ammonia sulfate to 1 M, mixing end-over-end for 15 
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minutes and clarified by centrifugation at 15,000 g for 30 minutes. The conditioned 
lysate was applied to Phenyl Sepharose FF high sub resin which was pre-equilibrate by 
binding buffer (50 mM Tris pH 7 buffer with 1 M ammonia sulfate). Conditioned lysate 
and resin were incubated for 1 hour at room temperature before being loaded onto 
PolyPrep column. When the unbound sample flew through, 20 CV binding buffer were 
added on top of the gravity packed column to wash out the residual unbound proteins. 
Protein elution from Phenyl Sepharose was done in 2 stages: 0.5 M ammonia sulfate and 
0 M ammonia sulfate. Both elution solutions were buffered by 50 mM Tris at pH 7. 
Ceramic Hydroxyapatite (CHT) batch adsorption and elution. The clarified lysate 
went through overnight dialysis against pH 6.8, 5 mM sodium phosphate (NaP) buffer at 
4°C using SnakeSkin dialysis tubing (MWCO = 3.5 kDa, ThermoFisher Scientific). The 
conditioned lysate was then incubated with pre-equilibrated CHT resins (Type I, 80 µm) 
for 1 hour at room temperature with end-over-end mixing. Then, the lysate-resin mixture 
was loaded to PolyPrep column and the unbound fluids flew through the column to be 
collected as “flowthrough”. After the resin was washed by 20 CV of binding buffer (5 
mM NaP pH 6.8), the elution process was carried out by step-wise ascending NaP 
concentration buffers. The first elution buffer was 0.1 M NaP pH 6.8 buffer and the 
second one was 0.2 M NaP both at pH 6.8. 
HEA HyperCel low salt batch adsorption and elution. HEA HyperCel low salt 
binding condition was the same as the lysate condition (150 mM NaCl, 50 mM Tris, pH 
7). Therefore, no additional conditioning step was required. The clarified lysate was 
directly incubated with HEA HyperCel resin for 1 hour at room temperature which was 
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pre-equilibrated with binding buffer (50 mM Tris, pH 7 buffer with 150 mM NaCl). The 
lysate-resin mixture was then transferred into a PolyPrep Column and the flowthrough 
sample was collected by gravity. The resin then was washed by 20 CV binding buffer 
and the wash sample was also collected for further analysis. Protein elution was 
designed to be a 3-step process with 10 CV of each elution buffer. The first elution was 
achieved by 1 M NaCl, 50 mM Tris pH 7 buffer. The second elution was pH 5 100 mM 
sodium acetate (NaAc) buffer also with 1 M NaCl. The third elution buffer was pH 3 
100mM sodium citrate buffer with no NaCl addition. 
HEA HyperCel high salt batch adsorption and elution. Another binding condition 
tested for HEA HyperCel resin was at high salt concentration. Solid NaCl was added 
into clarified lysate to reach a final NaCl concentration of 3 M. After 15 minutes of end-
over-end mixing, the lysate was centrifuged at 15,000 g for 30 minutes to remove any 
precipitates that formed. The conditioned lysate was then incubated for 1 hour at room 
temperature with pre-equilibrate HEA HyperCel resin by the high salt binding buffer (50 
mM Tris, pH 7, 3 M NaCl). The lysate-resin mixture was then transferred into a 
PolyPrep Column and the flowthrough sample was collected by gravity. The wash and 
elution procedure following HEA high salt batch adsorption was exactly the same as 
HEA low salt batch adsorption. 
PPA HyperCel low salt batch adsorption and elution. The PPA low salt batch 
adsorption and elution experiment followed the same protocol as HEA low salt batch 
adsorption and elution experiment. 
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PPA HyperCel high salt batch adsorption and elution. Similarly, the PPA low salt 
batch adsorption and elution experiment followed the same protocol as HEA high salt 
batch adsorption and elution experiment. 
Capto adhere batch adsorption and elution. For Capto adhere adsorption, the 
same adsorption conditions and lysate conditioning steps as Capto Q adsorption were 
applied. The Elution process for Capto adhere was different from Capto Q to achieve the 
optimal purification power for Capto adhere. Elution was designed to have 3 stages of 
descending pH change (pH 5, 4, and 3). All elution buffers were 0.1 M citrate-phosphate 
buffer with no extra salt addition. 
MEP HyperCel batch adsorption and elution. MEP HyperCel batch adsorption 
and elution used the same procedure as the high salt conditions as HEA and PPA 
HyperCel. 
2.5 Packed-bed purification of OPN 
ÄKTA Purifier (GE healthcare life sciences) carried packed-bed chromatography 
purification and process optimization. The top two resin performers from batch 
adsorption experiments were evaluated in a 1 mL prepacked column format. PRC HEA 
HyperCel (1 ml) was purchased from Pall and HiTrap Capto Q (1 ml) from GE 
Healthcare. The same feed composition and load volume was used on prepacked 
columns to allow for verification and comparison between batch adsorption and packed-
bed chromatography data. 
The general protocols for packed-bed chromatography in this research are as 
follow. The volumetric flow rate was controlled at 0.2 ml/min to ensure 5 minutes 
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residence time during sample loading. The same linear velocity was used for the wash 
and elution steps. Protein concentration during chromatography and ionic strength of 
elution buffers was by monitored continually by absorbance reading at 280 nm and 
conductivity measurement, respectively. Eluted fractions (1 ml) were collected in 
fraction collector (Frac-950, GE healthcare life sciences) and analyzed for total protein 
by Bradford assay and OPN by ELISA. The elution process was the subject to change 
and optimization on packed-bed chromatography. 
HEA HyperCel resin performance verification and optimization. To verify 
performance of HEA HyperCel from batch adsorption experiments on packed-bed 
columns and further optimize the purification process, clarified lysate (in pH 7 50 mM 
Tris buffer containing 150 mM NaCl) was loaded onto the equilibrated PRC HEA 
HyperCel column and washed by 20 CV of binding buffer. Linear NaCl gradient (0.15 to 
1.5 M NaCl over 20 CV) in 50 mM Tris at pH 7 was applied as the elution process. 
Capto Q resin performance verification and optimization. To verify performance 
of Capto Q on packed-bed columns and optimize the purification process, clarified lysate 
was dialyzed against pH 7 50 mM Tris buffer overnight to bring conductivity below 5 
mS. Then loaded onto the equilibrated HiTrap Capto Q column. After washing by 20 CV 
of binding buffer, linear NaCl gradient (0 to 1.0 M over 20 CV) in 50 mM Tris at pH 7 
was applied to elute bound proteins: 
OPN purification by HEA-Q 2-step process. Clarified lysate (in pH 7 50 mM 
Tris buffer containing 150 mM NaCl) was directly loaded onto the equilibrated PRC 
HEA HyperCel column and washed by 20 CV of binding buffer. A single step change 
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elution was used for OPN recovery from HEA. The elution buffer was 50 mM Tris pH 7 
buffer containing 1 M NaCl. The first 8 CV of elution fraction was collected as the HEA 
purified pool. The partially purified OPN from HEA HyperCel elute was dialyzed 
against 50 mM Tris pH 7 buffer overnight at 4°C for salt removal. Dialyzed HEA eluate 
(conductivity <5 mS)), was loaded on HiTrap Capto Q (1 ml) as previous protocols, 
washed with 20 column volumes of the binding buffer (50 mM Tris, pH 7, 4 mS). After 
the wash procedure, 0 – 1 M NaCl linear gradient elution (20 CV) was applied to Capto 
Q for OPN purification. 
OPN purification by Q-HEA 2-step process. The process for Capto Q as capture 
chromatography step was the same as its performance verification and optimization. The 
fractions between 32 mS/cm and and 49 mS/cm were collected as the partially purified 
OPN pool. The pool was then diluted by 50 mM Tris pH 7 buffer 3 times to reduce the 
conductivity for HEA HyperCel low-salt binding. The binding, washing and eluting for 
HEA HyperCel was actually the same as the process. Then, HEA was used as the 
capture step. The elute from HEA was collected as the purified OPN by Q-HEA 2-step 
process. 
2.6 Analytical methods 
2.6.1 Bradford assay for total protein (TP) determination 
The total protein concentration in clarified cell lysate and fractions collected in 
all the experiments was determined by Bradford assay53 in 96-well plates with bovine 
serum albumin (BSA) standards (Pierce™ Coomassie Plus (Bradford) Assay Kit, 
ThermoFisher Scientific). 
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The protein concentration standards were made by diluting 2 mg/ml BSA stock 
solution included in the kit in PBS to concentration 1500, 1000, 750, 500, 250, 125, 100, 
and 25 µg/ml. The samples for total protein quantification were diluted in PBS if out of 
the range of standard curve. Samples and standards were dispended in 96-well plate in 
triplicates and mixed with Coomassie Plus Blue stain from the kit and incubated in room 
temperature for 10 minutes. The absorbance was read at 595 nm wavelength by VERSA 
max microplate reader (Molecular Devices, Sunnyvale, CA, USA). 
2.6.2 ELISA (enzyme-linked immunosorbent assay) for OPN quantification 
The standards were prepared from FLAG-BAP (Sigma-Aldrich P7582) diluted in 
PBS to concentration standards ranging from 15 ng/ml to 1000 ng/ml. The samples were 
also diluted in PBS to match the range of the standard curve. Standards and diluted 
samples were dispensed in 96-well plate (Nunc Maxisorp immuno plate, Thermo Fisher) 
at 100 µl/well and incubated at 4°C overnight. After blocking by 3% BSA, the FLAG 
tagged protein were detected by 1:5000 diluted anti-FLAG M2 antibody conjugated with 
Horseradish peroxidase enzyme (HRP) (Sigma-Aldrich A8592). The plate then was 
developed for 5 minutes by the addition of TMB liquid substrate (Sigma-Aldrich T0440) 
and then the reaction was ended by adding 2 N HCl. The absorbance was read at 450 
nm. 
2.6.3 SDS- PAGE and Western- blot for product quality measurement 
The purified fractions along the process were analyzed by SDS-PAGE (Sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis) for OPN purity. The samples were 
mixed with sample buffer (NuPAGE LDS Sample buffer 4x, ThermoFisher scientific) 
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which contains 10% reducing agent and heated to 70°C for 10 min. The reduced sample 
then were loaded onto the NuPAGE 4-12% Bis-Tris Gel (Invitrogen, USA) and the 
electrophoresis was carried out at 200 V for 35 minutes. Next, gels were removed from 
the cassette, blocked 45 min in the blocking buffer (10% acedic acid, 40% ethanol, and 
50% RO water), stain for 3 hours by SimpleBlueTM Safe Stain (Novex, ThermoFisher 
Scientific) and then destained overnight in RO water overnight. 
For Western-blotting, the protein was transferred to PVDF membrane (Invitrogen 
iBlot Gel Transfer Stacks, PVDF, mini). The membrane was then blocked by 3% non-fat 
milk for 1 hour. The immobilized protein was detected by 1:2000 diluted anti-FLAG M2 
antibody conjugated with alkaline phosphatase (Sigma- Aldrich A9469). 
2.7 Resin performance evaluation 
The OPN capture performances of candidates resins were evaluated by two major 
parameters—purification factor and OPN recovery. The fractions collected from batch 
adsorption and elution experiments were analyzed by Bradford assay for total protein 
concentration and ELISA for OPN concentration. The purity of clarified lysate and 
fractions from batch adsorption and elution experiments were calculated by the equation 
below. 
𝑃𝑢𝑟𝑖𝑡𝑦 =
𝑂𝑃𝑁 (
𝑚𝑔
𝑚𝑙 )
𝑇𝑃 (
𝑚𝑔
𝑚𝑙 )
× 100% 
The recovery of each candidate resin was calculated by dividing the amount of 
OPN (mg) from the elution fraction with the majority of OPN by the amount of OPN 
from the conditioned cell lysate (feed). 
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𝑅𝑒𝑐𝑜𝑣𝑒𝑟𝑦 =
𝑂𝑃𝑁 (𝑚𝑔)𝑖𝑛 𝑡ℎ𝑒 𝑂𝑃𝑁 𝑒𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛
𝑂𝑃𝑁 (𝑚𝑔) 𝑖𝑛 𝑡ℎ𝑒 𝑓𝑒𝑒𝑑
× 100% 
Purification factor of each candidate resin was defined as the ratio of purity of 
the elution fraction with the majority of OPN and the purity of the feed. 
𝑃𝑢𝑟𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 =
𝑃𝑢𝑟𝑖𝑡𝑦 𝑜𝑓 𝑡ℎ𝑒 𝑂𝑃𝑁 𝑒𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛
𝑃𝑢𝑟𝑖𝑡𝑦 𝑜𝑓 𝑡ℎ𝑒 𝑓𝑒𝑒𝑑
× 100% 
 
2.8 Statistical analysis 
The statistical analysis used in this article was performed by JMP software. 
2.8.1 Response surface analysis for HTS results 
HTS experiments were used to analyze the response of protein-ligand interaction 
to different conditions. The OPN and TP bound to the resin after equilibrium binding in 
the 96-well plate was the difference between the feed and the flowthrough. The fraction 
of OPN and TP bound to the resin was normalized against the protein concentration in 
the feed. Response surface analysis was applied to the fraction of the bound OPN and TP 
with pH and NaCl concentration being the factors. Prediction contour profiles of OPN 
and TP adsorption were generated based on response surface analysis results. 
2.8.2 Least square fitting for resin comparison 
After OPN purification factor and recovery data was collected by batch 
adsorption and elution experiments, lease square fitting model from JMP Pro software 
was used to evaluate and compare the performance of different resins. 
The first step was to test if different resin yielded significantly different OPN 
purification performance. The responses in this statistical analysis were OPN recovery 
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and purification factor. The type of resins was the factor to test. The factor levels were 
the different resins investigated in this study. For HEA HyperCel and PPA HyperCel 
resins, two bind/elute processes (low-salt and high-salt process) were investigated using 
batch adsorption experiments. Each low- and high-salt process conditions were analyzed 
as individual levels. As a result, a total of 9 levels were tested: Capto Q, Capto adhere, 
CHT, Phenyl Sepharose, HEA HyperCel (low-salt), HEA HyperCel (high-salt), PPA 
HyperCel (low-salt), PPA HyperCel (high-salt) and MEP HyperCel. Since the batch 
adsorption experiments were carried out on multiple days with freshly extracted lysate, 
the date of experiments was treated as a randomized factor to block the variation 
associated with the date of experiment and help isolate the effect due to type of resins. 
Least square fitting analysis was carried out assuming constant standard error. The report 
included the P-value of fixed factor on the responses as well as the effect of randomized 
factor. A P-value of less than 0.05 indicated that tested resins had a significantly 
different performance in terms of OPN recovery and purification. 
Once the difference in performance was confirmed, the second step was to 
identify the better performers among the candidate resins. Each Pair Student’s test was 
conducted to compare the effects between resins based on the least square means 
generated by the test described in the previous paragraph at α = 0.05 level. The test 
results with different letters indicate significantly different effect on the response. The 
connecting letter reports were used to rank and compare resin performance. 
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3 RESULTS AND DISCUSSION  
3.1 Resin adsorption and elution studies 
The low expression level (1.2 mg/g wet biomass) and initial OPN concentration 
in E. coli lysate of 2-3% total soluble protein is a process development challenge for any 
group that aims to come up with efficient and scalable purification processes. The 
typical goal for early stage process development is to achieve higher than 90% target 
protein purity in no more than three chromatographic steps. The overall process yield is 
difficult to set in advance, but 80% yield per step was a target that we set for OPN 
purification. 
The first step for designing an efficient protein purification process is to screen 
candidate chromatography media (resins), evaluate their performance, and identify the 
best performers for further optimization. In the search of efficient adsorbents for OPN 
purification, we first evaluated most common orthogonal chemistries i.e. anion exchange 
and hydrophobic interaction resins. 
3.1.1 OPN adsorption and elution studies with anion exchange resin (Capto Q) 
The relatively low isoelectric point of OPN (4.3) allows strong electrostatic 
interaction between OPN and the anion exchange resins in a wide range of pH 
conditions. Preliminary adsorption data using clarified E. coli lysates indicated that OPN 
binds efficiently in the pH range between 6 and 8. However, at pH 8, significantly more 
E. coli host cell protein (HCP) bound to the adsorbent compared to pH 6 and 7. Because 
pH 7 is the condition of OPN extraction, this condition was chosen for further evaluation 
of OPN interaction with Capto Q – a strong anion exchange resin. 
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Clarified and conditioned OPN recombinant E. coli lysates (50 mM Tris, pH 7.0, 
<4 mS) were incubated with Capto Q resin for 1 h at room temperature as described in 
Materials and Methods. After washing the resin with binding buffer, OPN was eluted 
stepwise from the resin using 0.2 M, 0.5 M, and 1 M NaCl solution also buffered by 50 
mM Tris at pH 7. Total protein (TP) and OPN analysis of each fraction were plotted in 
Figure 4. The flowthrough sample contained 31% of unbound E. coil protein and less 
than 5% of OPN unbound. The first elution step (0.2 M NaCl) removed the bulk of 
adsorbed host cell protein (44% of the total protein in the feed) with about 2% loss of 
OPN. The second elution step eluted almost all of the bound OPN (92%) and the 
residual total protein (16%). Since the initial feed contained 4 mg/mL TP and 0.16 
mg/mL OPN, we can conclude that this two-step elution could achieve a six- fold 
increase in OPN purity (from 4% to 23%) and 92% OPN recovery. From the standpoint 
of mass balance, this NaCl concentration step elution could recover 98% of OPN bound 
to Capto Q as well as 91% of E. coli total protein initially bound to the resin. 
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Figure 4  Batch adsorption and elution of OPN and total protein (TP) on anion exchange 
resin (Capto Q). Adsorption condition was 50 mM Tris buffer at pH 7. Elution steps 
were conducted with 50 mM Tris, pH 7 containing 0.2 M, 0.5 M, and 1 M NaCl, 
respectively. The data reported were percentage normalized against the amount in the 
feed. The adsorption experiments were performed in triplicate and bars represent the 
standard deviation. 
 
3.1.2 OPN adsorption and elution studies with a hydrophobic interaction resin (Phenyl 
Sepharose) 
Hydrophobic interaction chromatography (HIC) is often applied as an orthogonal 
step to ion exchange chromatography and in some situations as a capture step of 
properly adjusted lysates (feed) with ammonium sulfate. To determine maximum 
ammonium sulfate concentration that can be applied to adjust clarified E. coli lysates for 
optimal OPN binding to Phenyl Sepharose, 1.0 and 1.5 M ammonium sulfate 
concentrations were tested. The presence of ammonium sulfate in pH 7 lysates at final 
concentration of 1.0 M or 1.5 M resulted in partial precipitation of OPN and host cell 
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proteins (HCP) (Table 5). After removing the precipitated protein by centrifugation, we 
determined that about 20% OPN was lost with 1.0 M and 37% in the presence of 1.5 M 
ammonium sulfate. The amount of total proteins was reduced by 19% and 28%, 
respectively. Although, 1.5 M provided a better adsorption of OPN from the lysate, 37% 
initial loss of OPN was far from ideal. Because no gain of OPN enrichment factor was 
achieved to counter balance the loss, we decided to test OPN adsorption from clarified 
lysates containing 1.0 M ammonium sulfate. 
 
Table 5  Effect of ammonium sulfate addition to E. coli lysate on OPN and TP 
loss due to precipitation. The pellets formed by ammonium sulfate precipitation were 
removed by centrifugation. OPN and TP recovery in the supernatant and enrichment 
factors of ammonium sulfate were listed. (The experiments were done in triplicates; data 
shown with the standard deviation) 
Ammonium Sulfate 
Concentration 
OPN Recovery TP Recovery Enrichment 
Factor 
1.0 M 79.8% ± 4.6% 88.9% ± 1.7% 0.90 ± 0.06 
1.5 M 62.8% ± 4.0% 84.3% ± 2.1% 0.75 ± 0.07 
 
About 20% OPN was lost in the flowthrough and wash fractions after equilirum 
binding with 1.0 M ammonium sulfate. Two steps of descending ammonium sulfate 
concentration (0.5 M and 0 M) were used for the elution of adsorbed protein. About 71% 
of OPN was recovered by 0.5 M ammonium sulfate elution and a purification factor of 
2.9 was achieved. The second elution step with no ammonium sulfate desorbed the rest 
of OPN bound with no increase in OPN purity (Figure 5). 
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Figure 5  Batch adsorption and elution of OPN and E. coli total proteins by HIC 
(Phenyl Sepharose). Adsorption was done from conditioned E. coli lysate which 
contained 1.0 M ammonium sulfate at pH 7. Elution steps were 0.5 M ammonium sulfate 
and 0 M ammonium sulfate. All solutions in this experiment were buffered by 50 mM 
Tris at pH 7. The data reported were percentage normalized against the amount in the 
feed. The adsorption experiments were performed in triplicate. Bars represent the 
standard deviation. 
 
3.1.3 OPN adsorption and elution studies with ceramic hydroxyapatite (CHT) 
Since binding to calcium is one of the important and differentiating 
characteristics of OPN, ceramic hydroxyapatite (CHT) were considered a good candidate 
to test OPN adsorption from cell lysate. The binding and elution conditions with CHT 
were chosen based on vendor’s recommendations that were slightly modified for OPN 
purification. 
CHT showed adsorption preferences for OPN from clarified E. coli lysate 
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steps (0.1 M and 0.2 M sodium phosphate buffer at pH 6.8) were used as elutions. The 
majority of OPN (61%) was eluted with 0.1 M sodium phosphate buffer also at pH 6.8. 
The rest of OPN was all recovered in the second step using 0.2 M sodium phosphate. 
Similarly, all the protein adsorbed was eluted in two steps by 0.1 M and 0.2 M sodium 
phosphate respectively (Figure 6). Despite the exhibited adsorption selectivity for OPN, 
CHT failed to show greater purification capacity than HIC (Phenyl Sepharose) resin. The 
achieved purification fold of OPN with CHT was only 2.3 fold. 
 
 
Figure 6  Batch adsorption and elution of OPN and total proteins (TP) using 
ceramic hydroxyapatite. Adsorption was performed from E. coli clarified lysate dialyzed 
against 5 mM sodium phosphate buffer at pH 6.8. Elution 1: 0.1 M sodium phosphate 
buffer pH 6.8; Elution 2: 0.2 M sodium phosphate buffer pH 6.8. 
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3.1.4 OPN adsorption and elution studies with mixed-modal resins 
The acidic and hydrophobic nature of OPN led us to search for an efficient 
capture resin among the mixed-modal resins that possess anionic and hydrophobic 
interaction properties. Commercial mixed-modal chromatography sorbents that were 
evaluated include Capto adhere (GE Health), HEA Hypercel, PPA Hypercel and MEP 
Hypercel (Pall). Resin performance was judged based on OPN recovery yield and 
purification factor. 
3.1.4.1 HEA HyperCel adsorption/elution study 
HEA HyperCel has cellulose based matrix with hexylamine ligand. This ligand 
has strong anionic (pKa ~ 10) and hydrophobic properties at neutral pH, which allows 
protein capture under physiological conditions38. 
To investigate the interaction between OPN and the HEA ligand, high-
throughput screening (HTS) experiments were conducted in the pH range from 5 to 9 
and salt concentrations from 0 to 3 M NaCl. The unbound OPN and total TP after 
equilibrium adsorption were quantified by ELISA and Bradford assay53 respectively. 
Response surface analysis was carried out by JMP Software and the prediction profiles 
of OPN and TP bound to HEA resin are shown as Figure 7. 
The contour profile of OPN adsorption (Figure 7A) shows that OPN adsorption 
increased in the whole pH range (pH 5 to 9) at any given salt concentration within the 
tested range. Salt concentration had a significant and interesting effect on OPN 
adsorption to HEA HyperCel sorbents. At salt concentrations below 0.5 M, the majority 
of OPN bound to the HEA primarily by electrostatic interaction. As the salt (NaCl) 
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concentration increased to 1 M range, charge interaction was substantially weakened 
resulting in reduced OPN bound fraction by as much as 50%. In the high-salt range 
(NaCl concentration >2.5 M) where hydrophobic interaction became more prevalent, 
adsorbed OPN fraction back to 70% - 90% level. The impact of pH and NaCl 
concentration on total protein is less dramatic than on OPN (Figure 7B), which is 
expected since the proteome of E. coli consists host cell proteins (HCPs) with different 
properties that would led to different responses to HEA ligand according to different 
conditions. Generally, higher NaCl concentration led to higher amount of adsorption. 
 
 
Figure 7  Contour profile of OPN (A) and total protein (B) bound to HEA 
HyperCel. Numbers on the contour grids represent the fraction of protein in the lysate 
that was adsorbed to HEA Hypercel. 
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The HTS results suggest that both high salt (3 M NaCl) and low salt condition 
(close to 0.1 M NaCl) would favor OPN adsorption in the whole pH range (5 to 9). Two 
(high and low-salt) adsorption conditions were selected for further investigation. For the 
batch adsorption under low salt condition, the clarified cell lysate was incubated directly 
with HEA resin for 1 hour at room temperature as described in Materials and Methods 
section. No resin conditioning was required as HTS results in Figure 7A predicted more 
than 90% of OPN would be bound from pH 7 50 mM Tris buffer containing 150 mM 
NaCl. 
Based on the screening results, we designed a 3-step elution process for complete 
desorption of OPN using a combination of pH and salt concentration changes that 
gradually weakened hydrophobic and charge interactions and eventually led to 
electrostatic repulsion. The elution steps consisted of 50 mM Tris buffer at pH 7 
containing 1 M NaCl, followed by pH 5 0.1 M sodium acetate buffer with 1 M NaCl and 
pH 3 0.1 M sodium citrate buffer without NaCl addition. The recovery of OPN and total 
soluble protein from the initial loading sample in each step are shown in Figure 8. 
As predicted by HTS data at pH 7, very small amount of OPN (5%) was detected 
in the flowthrough fraction, whereas more than 40% of E. coli total protein did not bind 
to HEA and remained in the flowthrough. After resin washing with the binding buffer, 
NaCl concentration was increased to 1 M for the first elution step while keeping the pH 
at 7. Because the majority of bound OPN (76%) was desorbed under those conditions 
and only 6% of the bound E. coli protein, this step alone resulted in 14-fold purification 
of OPN. While the rest of adsorbed OPN was recovered in the subsequent elution steps, 
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only 45% of E. coli proteins initially bound to HEA HyperCel were recovered. Complete 
desorption of strongly adsorbed proteins and regeneration of HEA would probably 
require using of 1 M NaOH. 
 
 
Figure 8  Low-salt batch adsorption and elution of OPN and E. coli total proteins 
using HEA HyperCel: Adsorption was performed from pH 7 E. coli clarified lysate 
containing 150 mM. Elution steps are pH 7 with 1 M NaCl, pH 5 with 1 M NaCl, and 
pH 3 with no NaCl addition. 
 
For adsorption experiments at high-salt, the resin was conditioned with the 
binding buffer (3.0 M NaCl, 50 mM Tris, pH 7) and clarified lysate (pH 7) was adjusted 
to 3.0 M NaCl concentration before incubation. The same elution steps and conditions as 
in the low salt adsorption experiments were applied (Figure 9). 
Under high salt conditions, hydrophobic interactions were the dominating factor. 
Compared to low-salt binding, more than 80% of E. coli protein was bound to HEA resin 
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with 10 column volumes of binding buffer, the first elution was done with 1 M NaCl at 
pH 7. The majority of OPN (74%) and 10% of E. coli protein were desorbed in the first 
elution step achieving 7-fold purification of OPN in a single step. The rest of the bound 
OPN was recovered in the two subsequent elution steps (Figure 9) but the residual 58% 
of E. coli proteins remained tightly bound to the resin. 
 
 
Figure 9  High-salt batch adsorption and elution of OPN and E. coli total soluble 
protein using HEA HyperCel: Adsorption was performed from conditioned E. coli 
clarified lysate with 3 M NaCl pH7. Elution steps were pH 7 with 1 M NaCl, pH 5 with 
1 M NaCl, and pH 3 with no NaCl addition. 
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the HEA HyperCel resin. The prediction contour profile of OPN bound to the PPA 
HyperCel is shown in Figure 10. 
Total protein behaved similarly on PPA HyperCel compared to HEA HyperCel 
reflecting the similarity of the ligand structure. However, over 90% of OPN was retained 
by PPA HyperCel under all the tested conditions. Clearly, the aromatic ring from PPA 
ligand provided much higher affinity for OPN than the aliphatic group from HEA. 
 
Figure 10  Contour profile of the proportion of OPN (A) and total protein (B) 
bound to PPA HyperCel. Numbers on the contour grids represent the fraction of protein 
in the lysate that was adsorbed to PPA HyperCel. 
 
The elution of adsorbed protein from PPA HyperCel was tested using exactly the 
same pH and salt conditions as with HEA HyperCel. As predicted by HTS, the E. coli 
proteins behaved similarly on both PPA HyperCel and HEA HyperCel resins but the 
OPN distribution in the eluted fractions was different. A small fraction of OPN was 
recovered in the first elution step (pH 7, 1 M NaCl) and almost none in the second. The 
majority of OPN (60%) was desorbed from PPA HyperCel at pH 3. Unfortunately, the 
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pH 3 elution fraction also contained a significant amount of E. coli host cell proteins, 
which led to lower purification factors (3-fold purification for low-salt binding 
conditions and 2.5-fold for high salt binding). No significant difference in the adsorption 
and elution profiles of OPN and total protein was observed between low salt (Figure 11) 
and high salt binding concentrations (Figure 12). 
Although 90% of OPN could be eluted from PPA HyperCel resin during pH 7 
and pH 3 elution, more than 60% of total protein remain adsorbed. 
 
 
Figure 11  Low-salt batch adsorption and elution of OPN and E. coli total 
soluble protein using PPA HyperCel: Adsorption was performed from E. coli clarified 
lysate containing 150 mM NaCl pH 7. Elution steps were pH 7 with 1 M NaCl, pH 5 
with 1 M NaCl, and pH 3 with no NaCl addition. 
 
-10.0%
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
Flowthrough Wash pH 7, 1 M NaCl pH 5, 1 M NaCl pH 3, 0 M NaCl
R
ec
o
ve
ry
Sample fraction
TP
OPN
 47 
 
 
Figure 12  High-salt batch adsorption and elution of OPN and E. coli total 
protein using PPA HyperCel: Adsorption was performed from conditioned E. coli 
clarified lysate containing 3 M NaCl at pH 7. Elution steps are pH 7 with 1 M NaCl, pH 
5 with 1 M NaCl, and pH 3 with no NaCl addition. 
 
3.1.4.3 Capto adhere adsorption studies 
Capto adhere is a strong multimodal anion exchanger (N-benzyl-n-methyl 
ethanolamine) designed to bind proteins via ionic, hydrogen, and hydrophobic 
interactions. The hydrophobicity of Capto adhere ligand is reported to be reduced by the 
presence of multiple hydroxyl groups38. HTS designed similarly to HEA and PPA resin 
screening were carried out to investigate interaction between OPN and Capto adhere. As 
shown in Figure 13, NaCl a concentration had significant impact on OPN adsorption to 
Capto adhere. The fraction of adsorbed OPN decreased with the increase of NaCl 
concentration indicating that the predominant interactions between OPN and Capto 
adhere ligands were ionic. OPN binding with Capto adhere at high pH condition was 
also tested. Unlike HEA Hypercel, the hydrophobic interaction failed to take over even 
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when NaCl concentration increased to 3 M. At pH 7 and 3 M NaCl, more than 70% of 
OPN remained in the flowthrough fraction (data not shown). Therefore, salt removal by 
dialysis/diafiltration was a necessary conditioning step for OPN adsorption to Capto 
adhere from E. coli lysate. 
 
Figure 13  Contour profile of the proportion of OPN (A) and total protein (B) 
bound to Capto adhere. Numbers on the contour grids represent the fraction of protein in 
the lysate bound to the Capto adhere. 
 
Adsorption and elution experiments were carried out using dialyzed cell lysates. 
Preliminary elution data established that stepwise protein desorption with a descending 
pH buffer (0.1 M citrate- phosphate buffer at pH 5, 4 and 3), suggested by the resin 
vendor (GE Healthcare), was optimal for purification of OPN. Around 8% of OPN and 
30% of host cell protein remained in the flowthrough (Figure 14). After the resin wash 
step with the binding buffer, additional 16% of host cell proteins were eluted at pH 5 and 
pH 4 and less than 2% of OPN at pH 4.  The majority of OPN (78%) was recovered in 
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the third elution step when the buffer pH was lowered to 3, a pH below OPN pI. During 
this last stage about 17% of E. coli total protein co-eluted with OPN, which resulted in 
4.6-fold OPN purification. Contrary to traditional strong anion exchanger such as Capto 
Q, only 51% of E. coli protein adsorbed to Capto adhere could be recovered, which 
indicates the benzene ring provides additional binding capacity to the quaternary amine. 
And recycling the sorbent would require deep cleaning. 
 
 
Figure 14  Batch adsorption and elution of OPN and E. coli total soluble protein 
by Capto adhere, E. coli clarified lysate was dialyzed to remove salt before adsorption. 
Binding condition: pH 7 50 mM Tris Buffer. Elution 1 - 3: Citrate-phosphate buffer pH 
5, pH 4, pH 3. 
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mercapto-ethyl- pyridine) appears to be more hydrophobic than traditional HIC resin 
such as Phenyl Sepharose. Thus, 0.5 M ammonium sulfate or 3.0 M sodium chloride was 
sufficient to promote OPN adsorption. These salt concentrations resulted in substantially 
less OPN precipitation than 1.0 M ammonium sulfate required for OPN adsorption to 
Phenyl Sepharose. 
We tried several elution strategies by various combinations of pH and salt 
concentrations and determined that OPN could not be recovered in a single fraction. The 
OPN recovery by decreasing pH and salt concentration is presented in Figure 15. The 
fraction with the highest OPN yield of 40% was recovered during the second elution step 
(pH 5 containing 1 M NaCl). This pool, contained 14% of E. coli total proteins, achieved 
three-fold purified OPN. Similar to the other two HyperCel resins, only half (53%) of 
the total protein bound to MEP and almost 100 % OPN were recovered in the three 
elution steps (Figure 15). Intensive cleaning and regeneration protocols are needed here 
for resin recycling. 
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Figure 15  Batch adsorption and elution of OPN and E. coli total protein using 
MEP HyperCel: Adsorption was performed from pH 7 E. coli clarified lysate containing 
3 M NaCl. Elution steps are pH 7 with 1 M NaCl, pH 5 with 1 M NaCl, and pH 3 
without NaCl addition. 
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3.1.5 Resin performance evaluation and comparison 
All the batch adsorption and step elution experiments were done in triplicates 
with similar loading capacities. OPN recovery and purification fold data in Table 6 were 
normalized against the initial protein content in the conditioned cell lysate (feed).  
Least square fitting test was carried out to test the effects of resins on OPN 
recovery and purification factors. As a result, the effect of the type of resins on OPN 
recovery has a P-value of 0.0168, which means different resins yielded significantly 
different OPN recovery. The P-value of OPN purification factor given by JMP Pro was 
less than 0.0001 suggesting the different resins performed dramatically different in terms 
of OPN purification. The variation due to the date of experiment contributed 38% and 
50% of variance to OPN recovery and purification factor respectively, according to 
REML (residual maximum likelihood) variance component estimates given by JMP Pro, 
which means day-to-day variation had significant effects on response and blocking it 
was necessary to help isolating the effects of type of resins on OPN recovery and 
purification. This day-to-day variation was most likely due to that the sonication for 
protein extraction was not ideally robust. High pressure homogenization would be a 
more robust protein extraction method that could help solve this issue introduced by 
sonication when the process was scaled-up to the point where homogenization were 
applicable. 
Knowing that different resins significantly yielded different OPN recovery and 
purification factors, each pair Student’s test at 95% confidence (α = 0.05) were carried 
out on the least square means of OPN recovery and purification factor to compare the 
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performance between resins. The results were given in connecting letters reports. The 
letters were marked in Table 6. The resins having the same letter marked on the recovery 
or purification factor had no significantly different performance in terms of OPN 
recovery or purification respectively. 
The binding and eluting conditions, purification factors, and OPN recoveries are 
presented in Table 6 for comparison. The data in Table 6 includes a single OPN elution 
step that yielded the highest recovery although in several cases achieving the highest 
OPN purification fold required additional elution steps. 
The ranking of resins in Table 6 was primarily based on purification factor for 
the OPN specific recovery and OPN recovery was also taken into account during the 
ranking process. The top resin candidates for further process development and scale up 
are HEA HypeCel (low salt lysate), Capto Q, and HEA HyperCel (high salt lysate). HEA 
HyperCel (low salt lysate) ranked first thanks to its exceptional 14-fold purification and 
its 76% recovery was among the highest as well. HEA HyperCel efficiently captured 
OPN directly from the clarified cell lysate without any additional lysate conditioning 
steps. From a manufacturing view point, direct OPN capture would save operating time 
and expenses associated with conditioning of a large volume-low initial purity OPN 
extracts. 
Capto Q was ranked at the second place because its 92% recovery is the highest 
in all candidates. And the 6-fold purification achieved by Capto Q was just shy from the 
14-fold from HEA HyperCel but significantly higher than other resins tested. It should 
be noted that achieving a 6-fold purification with Capto Q required resin wash with 50 
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mM Tris buffer, pH 7 containing 0.2 M NaCl to remove 44% of co-adsorbed E. coli 
proteins (Figure 4). The least amount of OPN that remained unbound after equilibrium 
adsorption is an indication of resin’s high binding capacity. The requirement for a salt 
removal step and an intermediate wash step was the major downside of Capto Q when 
compared with HEA HyperCel. 
HEA HyperCel (high salt) was the third best performer due to its 7-fold 
purification and a decent 74% recovery. The fact that HEA HyperCel worked under two 
vastly different conditions reveals the potential and versatility of the resin.  
The rest of the candidates resulted in significantly lower purification factors, so 
they were not chosen for further development.  
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Table 6  Comparison of resins by batch purification experiments, their respective 
purification factors and recoveries. Recovery and purification factors are expressed as 
mean ± standard deviation. Values having the same letters are not significantly different. 
Resin Binding 
Condition 
OPN Elution 
Condition 
Purification 
Factor 
Recovery 
(%) 
HEA 
HyperCel 
(Low-Salt) 
50 mM Tris, pH 
7, 0.15 M NaCl 
50 mM Tris, pH 
7, 1 M NaCl 
13.99 ± 2.86A 76.4 ± 
15.0A,B 
Capto Q 50 mM Tris pH 7 50 mM Tris pH 7, 
0.5 M NaCl 
5.92 ± 0.73B,C 92.0 ± 
15.4A 
HEA 
HyperCel 
(High-Salt) 
50 mM Tris, pH 
7, 3 M NaCl 
50 mM Tris, pH7, 
1 M NaCl 
7.10 ± 2.98B 74.1 ± 
20.3A,B 
Capto adhere 50 mM Tris pH 7 pH 3 citrate 
phosphate buffer 
4.61 ± 0.73C,D 78.1 
±17.0A,B 
PPA 
HyperCel 
(Low-Salt) 
50 mM Tris, pH 
7, 0.15 M NaCl 
0.1 M sodium 
citrate, pH 3 
3.05 ± 
0.87C,D,E 
59.6 ± 
15.9B,C 
Phenyl 
Sepharose 
50 mM Tris, pH 
7, 1 M 
ammonium 
sulfate 
50 mM Tris, pH 
7, 0.5 M 
ammonium 
sulfate 
2.88 ± 0.69D,E 71.2 ± 
21.9A,B 
PPA 
HyperCel 
(High-Salt) 
50 mM Tris, pH 
7, 3 M NaCl 
0.1 M sodium 
citrate, pH 3 
2.48 ± 1.19E 59.1% ± 
19.0%B,C 
CHT 5 mM Phosphate, 
pH 6.8 
0.1 M Phosphate, 
pH 6.8 
2.34 ± 0.36E 61.3%± 
15.6%B,C 
MEP 
HyperCel 
50 mM Tris, pH 
7, 3 M NaCl 
0.1 M Sodium 
acetate pH 5, 1 M 
NaCl 
2.82 ± 1.01D,E 39.4% ± 
3.8%C 
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3.1.6 Resin performance verification and optimization on packed-bed columns 
To confirm the validity of batch adsorption results, the processes used in batch 
adsorption experiments were repeated using packed-bed columns operated by ÄKTA 
Purifier chromatography system. The best resin candidates from Table 6 (HEA and 
Capto Q) were tested in a packed-bed adsorption configuration. The same feed 
composition and load volume was used on 1-ml prepacked columns (PRC HEA 
HyperCel 1 ml, HiTrap Capto Q 1 ml) to allow the comparison of achieved purification 
fold and OPN recovery between batch adsorption and packed-bed chromatography. The 
flow rate was controlled at 0.2 ml/min to ensure a 5-minute residence time during 
binding, and kept constant throughout wash and elution processes. 
For HEA HyperCel under low salt binding conditions, 6 ml of clarified lysate 
was directly loaded to equilibrated PRC HEA HyperCel column (1 ml). After 20 column 
volumes of wash with loading buffer, linear NaCl concentration gradient elution (0.15 M 
– 1.5 M NaCl over 20 column volumes, in pH 7 50 mM Tris buffer) was carried out. The 
OPN concentrations in the collected fractions determined by ELISA were plotted in 
Figure 16. OPN concentration followed the same trend as the A280 peak which reached 
maximum at buffer containing 1 M NaCl. The pooled (36-50 ml, 0.6 M NaCl to 1.1 M 
NaCl) fractions contained 97% of loaded OPN amount compared to 76.4 % from the 
batch adsorption. The difference between column gradient and step desorption in terms 
of OPN yield was that the reported 76.4% referred to OPN yield obtained from the 
single 1 M NaCl step (Figure 8). Two additional elution steps, after the 1 M-NaCl step, 
increased the OPN recovery from 76.4 % to 93%. Gradient elution from packed-bed 
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HEA column resulted in 16-fold purification – a value similar to 14-fold achieved by 1 
M NaCl step.  In summary, the gradient elution of OPN from HEA was apparently more 
efficient probably because of the higher salt concentration reaching 1.2 M NaCl in 
fraction 52 mL. 
 
 
Figure 16  Chromatogram of HEA HyperCel low salt bind/elute operated by 
ÄKTA system. OPN eluted in the peak around 1 M NaCl illustrated between the red-
dotted lines. 
 
HEA HyperCel packed bed column experiments using high-salt containing lysate 
did not work because of back-pressure build-up during loading. We believe the pressure 
build up was caused by the protein aggregation on the column, and decided not to 
proceed with the development of OPN purification under high-salt (3 M NaCl) binding 
conditions. 
Packed-bed purification of OPN with Capto Q resin was carried out after the 
dialysis of clarified lysate. The lysate ionic strength was reduced to below 5 mS/cm, as 
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determined in batch experiments, for maximal adsorption of OPN. The OPN elution was 
performed with a linear salt gradient (0 M to 1 M NaCl) over 20 column volumes. The 
majority of OPN was recovered in the 2 fractions (44 to 46 mL) at conductivities 
between 32 mS/cm and 49 mS/cm which correspond to 0.26 M and 0.45 M NaCl 
concentrations in 50 mM Tris buffer. The pooled protein fractions (43-46 mL) contained 
90% of the loaded OPN. The purity of OPN in this pool reached 22% resulting in 11-
fold purification, which is significantly higher than 6-fold achieved by step elution with 
0.5 M NaCl (Figure 4).  
 
 
Figure 17  Chromatogram of anion exchange chromatography. Dialyzed E. coli 
lysate loaded on HiScreen Capto Q column. Elution by ascending NaCl concentration 
linear gradient. OPN eluted between 0.26 M and 0.45 M NaCl illustrated between the 
red-dotted lines. 
 
0
20
40
60
80
100
120
0
1,000
2,000
3,000
4,000
5,000
6,000
0 10 20 30 40 50 60 70 80
C
o
n
d
u
ct
iv
it
y 
(m
S/
cm
)
A
b
so
rb
an
ce
 (
m
A
U
)
Volume (ml)
A280 (mAU) Cond (mS/cm)
 59 
 
Compared with batch adsorption results, prepacked columns on ÄKTA resulted 
in higher yield and purification fold. In batch adsorption experiments, the resins were not 
tightly packed resulting in back mixing. In addition to the lack of control over flow rate, 
there were significantly more variations in elution conditions and fraction collection for 
batch adsorption experiments than packed-bed chromatography on ÄKTA system. For 
Capto Q purification, the shortage of control over elution conditions and flowrate in 
batch adsorption experiments kept the process development from approaching small 
margin of condition optimization (0.2 M NaCl and 0.5 M NaCl elution steps in Figure 4) 
and ended up with lower purification factor (6 fold) than precisely controlled linear 
gradient and fraction collection by ÄKTA (OPN eluted between 0.26 M and 0.49 M 
NaCl with 11 fold purification). For HEA HyperCel the difference in adsorption mode 
(equilibrium binding vs dynamic binding) also contributed to the variability.  
Despite the variabilities, the results of batch adsorption experiments and 
prepacked columns on ÄKTA were comparable, indicating that batch adsorption and 
elution experiments in conjunction with HTS of resins could be used as a fast and low-
cost process development tool. 
It appears that HEA HyperCel (low salt) has better specificity for capturing OPN 
from crude and salt-containing E. coli lysates than Capto Q. On the other hand, Capt Q 
has high-adsorption capacity that would allow a significant OPN concentration from 
low-expressing E. coli strains. 
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3.2 Two-step OPN purification process design 
Since both resins demonstrated capture and purification potential, we tested their 
application in two orthogonal OPN purification trains: HEA followed by CaptoQ and 
CaptoQ followed be HEA processes. 
3.2.1 OPN purification by HEA-Q process 
In this purification scheme, HEA HyperCel served as the OPN capture step and 
Capto Q as a purification step. The clarified lysate was directly loaded to PRC HEA 
HyperCel (1 ml) column at linear velocity of 60 cm/h and washed by 20 column 
volumes of loading buffer. Since no separation of OPN from host protein was achieved 
by gradient elution i.e. a single peak containing HCPs and OPN in (Figure 16), one step 
elution with 50 mM Tris buffer, pH 7, containing 1 M NaCl was applied. The main 
driver for choosing a step elution over gradient was to obtain a higher-protein 
concentration pool and reduce elution buffer volume from 14 ml to 8 ml, the latter being 
important only on a manufacturing scale (Figure 18). 
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Figure 18  Chromatogram of HEA HyperCel low-salt binding and step elution. 
The elution peak was collected for Capto Q purification (23-31 ml).  
 
The partially purified OPN from HEA HyperCel elute was loaded to HiTrap 
Capto Q column (1 ml) after salt removal by dialysis. Dialyzed HEA eluate 
(conductivity <5 mS)), was loaded on HiTrap Capto Q (1ml) as before, washed with 20 
column volumes of the binding buffer (50 mM Tris, pH 7, 4 mS). After the wash 
procedure, 0 – 1 M NaCl linear gradient elution (20 CV) was applied to Capto Q as for 
further separation of OPN from E. coli HCPs. The linear NaCl concentration gradient 
generated 3 major peaks as depicted Figure 19. OPN was recovered in the second peak 
and marked between the red dotted lines in Figure 19 with improved purity. The details 
of OPN purification achieved by this process are given in Figure 20 and the purification 
table (Table 7).  
The capture step by HEA HyperCel yielded 81% recovery and elevated OPN 
purity from 2% in the crude lysate to 29%. The dialysis step was the necessary condition 
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step between chromatography steps and unfortunately caused 40% loss in a single step. 
The second purification step by Capto Q prove to be an orthogonal step to HEA and 
continue to purify OPN from 29% to 95% with 90% recovery. Overall, this 2-step 
purification process yielded 44% recovery with over 95% purity when considering the 
OPN fragment (Figure 20) which requires additional steps to remove if needed by 
specific application. 
This process took advantage of the salt-tolerant adsorption property of HEA 
HyperCel to eliminate conditioning step on the large-volume and low-purity lysate 
before capture chromatography. However, the HEA HyperCel pool contained 1 M NaCl 
that required extensive dialysis to remove. A significant OPN loss was observed during 
dialysis presumably due to protein binding to the dialysis membrane. The decrease of 
purity from 29% to 20% indicates that OPN was lost and less of E. coli HCPs. Because 
to OPN was not detected by ELISA in the dialysis buffer, we concluded that it was due 
to binding to the membrane. Several attempts to increase the yield seem to indicate that 
low sample volume to dialysis surface area ratio might be the cause for low recovery. On 
a larger scale, salt removal could be achieved by diafiltration on a tangential flow 
systems which should reduce protein loss for its much smaller surface area to volume 
ratio and the presence of constant sheer force. 
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Figure 19  Chromatogram of OPN purification on Capto Q following HEA 
HyperCel capture. 
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Figure 20  Purification of OPN by HEA and Capto Q two-step process. A: SDS-
PAGE with Coomassie stain (SimpleBlueTM SafeStain); B: Western-blot image. Both 
images are from the identical gel with the same sample loading in each lane. Lane 1: 
molecular weight markers; lane 2: E. coli clarified lysate; lane 3: Partially purified OPN 
fraction from HEA HyperCel elute; lane 4: Dialyzed HEA purified fraction as the feed 
for Capto Q chromatography; lane 5: Capto Q elute pool. For lane 2-5, total protein 
loading was kept constant at 5 µg/lane. 
 
Table 7  Purification of OPN from E. coli lysate by HEA-Q 2-step process 
Step Volume 
(ml) 
OPN 
(µg) 
Purity (%) Purification 
Fold 
Recovery 
(%) 
Clarified 
Lysate feed 
4.2 465.1 1.9* 1.0 100 
HEA 
HyperCel  
5.6 378.2 29* 15.6 81 
Dialysis 6.0 228.8 20* 0.7 49 
Capto Q  1.50 202.8 95 (including 
fragments); 60 (full 
length OPN)** 
3.5 44 
*Purity calculated from OPN concentration by ELISA and TP by Bradford assay. 
**Purity calculated by ImageJ software based on SDS-PAGE image. 
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3.2.2 OPN purification by Q-HEA process 
The alternative 2-step process train used a reversed order of resins: CaptoQ 
capture followed by HEA purification. The clarified lysate was first dialyzed to 
conductivity of 5 mS/cm before loading onto Capto Q column. The chromatogram of the 
Capto Q capture step was the same previously shown and discussed in Figure 17. The 
pooled OPN fractions from Capto Q, which had a conductivity of 45 mS/cm ( about 0.4 
M NaCl equivalent), was then diluted 3-fold to conductivity below 17 mS/cm for 
efficient adsorption to HEA HyperCel. The same step-change elution on HEA HyperCel 
was performed after 20 column volumes of wash as the capture step in previous process 
was used here as the second purification step. 
The data for this purification process are summarized in Table 8. Capto Q 
captured OPN from conditioned lysate and purified OPN from 2% purity to 22% with 
90% recovery and also reduced the volume by more than 2-fold. HEA HyperCel showed 
high specificity for elution pool from Capto Q and achieved 94% OPN purity by a single 
elution step. Overall, 50% recovery with 94% purity was achieved by this 2-step process 
(Table 8). 
OPN loss during dialysis of crude lysate was negligible while dialysis on 
partially purified OPN from the previous process resulted in significant loss. This was 
probably because the membrane was partially fouled by the bulk E. coli protein in the 
lysate and prevented major OPN binding to the dialysis membrane.  
The overall yield of Q-HEA process is slightly higher than HEA-Q process with 
the purity being identical. Therefore, the dynamic binding capacity of the two resins, and 
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the yield of diafiltration at larger scale are the deciding factors for which process is 
better for large scale manufacturing. 
 
Table 8  Purification of OPN from E. coli lysate by Q-HEA 2-step process 
Step Volume 
(ml) 
OPN 
(µg) 
Purity (%) Purification 
fold 
Recovery 
(%) 
Dialyzed Cell 
Lysate 
4.3 298.8 1.9* 1.0 100 
Capto Q 2 268.0 22* 11.7 90 
HEA 
HyperCel 
3 151.3 94 (including 
OPN fragments); 
79 (full length 
OPN) ** 
4.3 51 
*Purity calculated from OPN concentration by ELISA and TP by Bradford assay. 
**Purity calculated by ImageJ software based on SDS-PAGE image 
 
 
Figure 21  Purification of OPN by Q-HEA process SDS-PAGE (A) with 
Coomassie stain (SimpleBlueTM SafeStain) and Western-blot ((B) images. Lane 1: 
molecular weight marker; lane 2: E. coli clarified lysate; lane 3: Partially purified OPN 
fraction from Capto Q elute; lane 4-6: OPN elute fractions from HEA HyperCel. 
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4 CONCLUSION AND RECOMMENDATIONS  
4.1 Conclusion 
This research focused on the chromatography resin screening and 
chromatography process development for OPN purification from E. coli lysate. The 
development process went from high-throughput and small scale testing in 96-well 
plates to fine-tuning each step on packed-bed columns. 
A comprehensive investigation of four mixed-modal resins with hydrophobic and 
ionic characteristics revealed how subtle ligand chemistry differences affected OPN and 
E. coli HCPs adsorption. The four mixed-modal resins responded to variation of pH and 
salt concentration in a dramatically different fashion. Capto adhere, often categorized as 
a mixed-modal anion exchanger, behaved like a traditional anion exchanger and required 
low conductivity for efficient OPN adsorption. High ionic strength (> 0.5 M NaCl) or 
low pH (pH 3) conditions led to OPN elution. Unfortunately, the added hydrophobic 
feature of Capto adhere ligand failed to translate into a better performance in the case of 
OPN purification. HEA HyperCel proved to be mixed-modal resin with seemingly an 
optimal combination of hydrophobic interaction and anion exchanger properties. Protein 
adsorption happened at both low salt and high salt concentration conditions. At low salt 
condition (<0.5 M NaCl), OPN was retained by electrostatic interaction as the ligand and 
OPN were oppositely charged. Also, the hydrophobic arm of the ligand appeared to help 
achieving salt-tolerant adsorption (efficient binding with 0.15 M NaCl). Interestingly, 
when the salt concentration in the adsorption buffer increased to higher than 2.5 M NaCl 
values, the hydrophobic interaction mechanism took over and exerted strong affinity for 
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OPN. A close sibling of HEA HyperCel, PPA HyperCel behaved similarly to HEA, but 
unfortunately the aromatic ring on PPA ligand made it too hydrophobic for OPN, so 
OPN could not be easily eluted from PPA comparing to HEA. MEP HyperCel 
adsorption, on the other hand, did not work in a mixed-modal way during adsorption 
since the ligand had little charge when the pH was above its pKa of 4.8. OPN could bind 
to MEP HyperCel via hydrophobic interaction but could not be eluted in a single fraction 
with a decent yield and purity. 
Combination of batch adsorption and step elution experiments worked well as a 
resin performance evaluation and comparison method. Best performers could be easily 
identified by simple t-tests. The performance results from batch adsorption experiment 
were comparable to the results obtained with pre-packed columns operated by ÄKTA 
systems with much less time and buffer consumption. 
The best two performing resins - HEA HyperCel and Capto Q - utilized different 
chemistries for OPN adsorption allowing development of orthogonal purification trains. 
The two purification options tested (HEA-Q and Capto Q –HEA) yielded similar 
recovery of close to 50% and OPN purity of 95%. HEA-Q process fully took advantage 
of the salt-tolerant adsorption feature of HEA to eliminate conditioning step on the crude 
lysate, which could be beneficial for large scale manufacturing. However, OPN loss 
during dialysis between chromatography steps needed to be addressed before moving 
forward with this process. The Q-HEA process exploit the chromatofocusing feature of 
traditional ion exchange resin Capto Q for significant volume reduction during the 
capture step. HEA HyperCel worked well as a second step to further purify OPN. 
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4.2 Recommendation 
Suggestions for future work include: 
i. Determine the dynamic binding capacity of HEA HyperCel and Capto Q. 
Optimize the process to take advantage of the binding capacity of the two 
columns. 
ii. Develop a scalable diafiltration process for salt removal between the 
chromatography steps to eliminate OPN loss 
iii. Investigate viable bioseparation methods for OPN polishing step. An 
efficient polishing chromatography is required to remove OPN fragment 
and the remaining host cell protein should be removed in the polishing 
step. 
iv. Analyze the cell adhesion activity and other biochemical activities of 
purified OPN. Determine difference in activities of full length OPN and 
OPN fragment. 
 70 
 
REFERENCES 
1. Senger, D. R.; Asch, B. B.; Smith, B. D.; Perruzzi, C. A.; Dvorak, H. F., A 
secreted phosphoprotein marker for neoplastic transformation of both epithelial and 
fibroblastic cells. Nature 1983, 302 (5910), 714. 
2. Franzen, A.; Heinegård, D., Isolation and characterization of two sialoproteins 
present only in bone calcified matrix. Biochemical Journal 1985, 232 (3), 715-724. 
3. Senger, D. R.; Perruzzi, C. A.; Papadopoulos, A.; Tenen, D. G., Purification of a 
human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. 
Biochimica et Biophysica Acta (BBA)-Protein Structure and Molecular Enzymology 
1989, 996 (1-2), 43-48. 
4. Yuan, Y.; Zhang, X.; Weng, S.; Guan, W.; Xiang, D.; Gao, J.; Li, J.; Han, W.; 
Yu, Y., Expression and purification of bioactive high-purity recombinant mouse SPP1 in 
Escherichia coli. Applied biochemistry and biotechnology 2014, 173 (2), 421-32. 
5. Bayless, K. J.; Davis, G. E.; Meininger, G. A., Isolation and biological properties 
of osteopontin from bovine milk. Protein expression and purification 1997, 9 (3), 309-
314. 
6. Kazanecki, C. C.; Uzwiak, D. J.; Denhardt, D. T., Control of osteopontin 
signaling and function by post‐translational phosphorylation and protein folding. Journal 
of cellular biochemistry 2007, 102 (4), 912-924. 
7. Kurzbach, D.; Platzer, G.; Schwarz, T. C.; Henen, M. A.; Konrat, R.; 
Hinderberger, D., Cooperative unfolding of compact conformations of the intrinsically 
disordered protein osteopontin. Biochemistry 2013, 52 (31), 5167-5175. 
 71 
 
8. Fisher, L.; Torchia, D.; Fohr, B.; Young, M.; Fedarko, N., Flexible structures of 
SIBLING proteins, bone sialoprotein, and osteopontin. Biochemical and biophysical 
research communications 2001, 280 (2), 460-465. 
9. Kazanecki, C. C.; Uzwiak, D. J.; Denhardt, D. T., Control of osteopontin 
signaling and function by post-translational phosphorylation and protein folding. J Cell 
Biochem 2007, 102 (4), 912-24. 
10. Sørensen, E. S.; Petersen, T. E.; Højrup, P., Posttranslational modifications of 
bovine osteopontin: Identification of twenty‐eight phosphorylation and three O‐
glycosylation sites. Protein Science 1995, 4 (10), 2040-2049. 
11. Christensen, B.; Nielsen, M. S.; Haselmann, K. F.; Petersen, T. E.; Sørensen, E. 
S., Post-translationally modified residues of native human osteopontin are located in 
clusters: identification of 36 phosphorylation and five O-glycosylation sites and their 
biological implications. Biochemical Journal 2005, 390 (1), 285-292. 
12. Heinegård, D.; Hultenby, K.; Oldberg, Å.; Reinholt, F.; Wendel, M., 
Macromolecules in bone matrix. Connective Tissue Research 2009, 21 (1-4), 3-14. 
13. Reinholt, F. P.; Hultenby, K.; Oldberg, A.; Heinegård, D., Osteopontin--a 
possible anchor of osteoclasts to bone. Proceedings of the National Academy of Sciences 
1990, 87 (12), 4473-4475. 
14. McKee, M.; Nanci, A., Osteopontin at mineralized tissue interfaces in bone, 
teeth, and osseointegrated implants: ultrastructural distribution and implications for 
mineralized tissue formation, turnover, and repair. Microscopy research and technique 
1996, 33 (2), 141-164. 
 72 
 
15. Butler, W. T., Matrix Macromolecules of Bone and Dentin. Collagen and 
Related Research 1984, 4 (4), 297-307. 
16. Kitahara, K.; Ishijima, M.; Rittling, S. R.; Tsuji, K.; Kurosawa, H.; Nifuji, A.; 
Denhardt, D. T.; Noda, M., Osteopontin deficiency induces parathyroid hormone 
enhancement of cortical bone formation. Endocrinology 2003, 144 (5), 2132-40. 
17. Kleinman, J. G.; Beshensky, A.; Worcester, E. M.; Brown, D., Expression of 
osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney 
International 1995, 47 (6), 1585-1596. 
18. Hudkins, K. L.; Giachelli, C. M.; Cui, Y.; Couser, W. G.; Johnson, R. J.; Alpers, 
C. E., Osteopontin expression in fetal and mature human kidney. Journal of the 
American Society of Nephrology 1999, 10 (3), 444-457. 
19. Min, W.; Shiraga, H.; Chalko, C.; Goldfarb, S.; Krishna, G. G.; Hoyer, J. R., 
Quantitative studies of human urinary excretion of uropontin. Kidney Int 1998, 53 (1), 
189-93. 
20. Lieske, J. C.; Leonard, R.; Toback, F. G., Adhesion of calcium oxalate 
monohydrate crystals to renal epithelial cells is inhibited by specific anions. American 
Journal of Physiology-Renal Physiology 1995, 268 (4), F604-F612. 
21. Yamate, T.; Tsuji, H.; Amasaki, N.; Iguchi, M.; Kurita, T.; Kohri, K., Analysis of 
osteopontin DNA in patients with urolithiasis. Urological Research 2000, 28 (3), 159-
166. 
22. Atai, N. A.; Bansal, M.; Lo, C.; Bosman, J.; Tigchelaar, W.; Bosch, K. S.; 
Jonker, A.; De Witt Hamer, P. C.; Troost, D.; McCulloch, C. A., Osteopontin is up‐
 73 
 
regulated and associated with neutrophil and macrophage infiltration in glioblastoma. 
Immunology 2011, 132 (1), 39-48. 
23. Shevde, L. A.; Samant, R. S., Role of osteopontin in the pathophysiology of 
cancer. Matrix Biology 2014, 37, 131-141. 
24. Rangaswami, H.; Bulbule, A.; Kundu, G. C., Osteopontin: role in cell signaling 
and cancer progression. Trends Cell Biol 2006, 16 (2), 79-87. 
25. Anborgh, P. H.; Mutrie, J. C.; Tuck, A. B.; Chambers, A. F., Pre-and post-
translational regulation of osteopontin in cancer. Journal of cell communication and 
signaling 2011, 5 (2), 111-122. 
26. Cohen, S. N.; Chang, A. C.; Boyer, H. W.; Helling, R. B., Construction of 
biologically functional bacterial plasmids in vitro. Proceedings of the National Academy 
of Sciences 1973, 70 (11), 3240-3244. 
27. Pavlou, A. K.; Reichert, J. M., Recombinant protein therapeutics—success rates, 
market trends and values to 2010. Nature biotechnology 2004, 22 (12), 1513-1519. 
28. Altman, L. K., A new insulin given approval for use in US. New York Times 
1982, 30. 
29. Baeshen, M. N.; Al-Hejin, A. M.; Bora, R. S.; Ahmed, M.; Ramadan, H.; Saini, 
K. S.; Baeshen, N. A.; Redwan, E. M., Production of biopharmaceuticals in E. coli: 
current scenario and future perspectives. J Microbiol Biotechnol 2015, 25 (7), 953-962. 
30. Walsh, G., Biopharmaceutical benchmarks 2014. Nature biotechnology 2014, 32 
(10), 992. 
 74 
 
31. Walsh, G.; Jefferis, R., Post-translational modifications in the context of 
therapeutic proteins. Nature biotechnology 2006, 24 (10), 1241. 
32. Jang, J. H.; Kim, J. H., Improved cellular response of osteoblast cells using 
recombinant human osteopontin protein produced by Escherichia coli. Biotechnology 
letters 2005, 27 (22), 1767-70. 
33. Ashkar, S.; Teplow, D.; Glimcher, M.; Saavedra, R., In vitro phosphorylation of 
mouse osteopontin expressed in E. coli. Biochemical and biophysical research 
communications 1993, 191 (1), 126-133. 
34. GE Healthcare Lifesciences, Hydrophobic Interaction Chromatography (HIC) 
Selection Guide. 2012. 
35. Gagnon, P., IgG aggregate removal by charged-hydrophobic mixed mode 
chromatography. Current pharmaceutical biotechnology 2009, 10 (4), 434-439. 
36. Ghose, S.; Hubbard, B.; Cramer, S. M., Evaluation and comparison of 
alternatives to Protein A chromatography Mimetic and hydrophobic charge induction 
chromatographic stationary phases. Journal of chromatography. A 2006, 1122 (1-2), 
144-52. 
37. Guerrier, L.; Flayeux, I.; Boschetti, E., A dual-mode approach to the selective 
separation of antibodies and their fragments. Journal of Chromatography B: Biomedical 
Sciences and Applications 2001, 755 (1), 37-46. 
38. Pezzini, J.; Joucla, G.; Gantier, R.; Toueille, M.; Lomenech, A. M.; Le Senechal, 
C.; Garbay, B.; Santarelli, X.; Cabanne, C., Antibody capture by mixed-mode 
chromatography: a comprehensive study from determination of optimal purification 
 75 
 
conditions to identification of contaminating host cell proteins. Journal of 
chromatography. A 2011, 1218 (45), 8197-208. 
39. Arakawa, T.; Futatsumori-Sugai, M.; Tsumoto, K.; Kita, Y.; Sato, H.; Ejima, D., 
MEP HyperCel chromatography II: binding, washing and elution. Protein expression 
and purification 2010, 71 (2), 168-73. 
40. Brenac Brochier, V.; Chabre, H.; Lautrette, A.; Ravault, V.; Couret, M. N.; 
Didierlaurent, A.; Moingeon, P., High throughput screening of mixed-mode sorbents and 
optimisation using pre-packed lab-scale columns for the purification of the recombinant 
allergen rBet v 1a. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877 (24), 
2420-7. 
41. Coulon, D.; Cabanne, C.; Fitton, V.; Noubhani, A. M.; Saint-Christophe, E.; 
Santarelli, X., Penicillin acylase purification with the aid of hydrophobic charge 
induction chromatography. Journal of chromatography. B, Analytical technologies in the 
biomedical and life sciences 2004, 808 (1), 111-5. 
42. Brenac Brochier, V.; Schapman, A.; Santambien, P.; Britsch, L., Fast purification 
process optimization using mixed-mode chromatography sorbents in pre-packed mini-
columns. J Chromatogr A 2008, 1177 (2), 226-33. 
43. Cabanne, C.; Pezzini, J.; Joucla, G.; Hocquellet, A.; Barbot, C.; Garbay, B.; 
Santarelli, X., Efficient purification of recombinant proteins fused to maltose-binding 
protein by mixed-mode chromatography. J Chromatogr A 2009, 1216 (20), 4451-6. 
44. Zhao, G.; Dong, X. Y.; Sun, Y., Ligands for mixed-mode protein 
chromatography: Principles, characteristics and design. J Biotechnol 2009, 144 (1), 3-11. 
 76 
 
45. Hou, Y.; Cramer, S. M., Evaluation of selectivity in multimodal anion exchange 
systems: a priori prediction of protein retention and examination of mobile phase 
modifier effects. Journal of chromatography. A 2011, 1218 (43), 7813-20. 
46. Nfor, B. K.; Noverraz, M.; Chilamkurthi, S.; Verhaert, P. D.; van der Wielen, L. 
A.; Ottens, M., High-throughput isotherm determination and thermodynamic modeling 
of protein adsorption on mixed mode adsorbents. Journal of chromatography. A 2010, 
1217 (44), 6829-50. 
47. Zhao, G.; Dong, X.-Y.; Sun, Y., Ligands for mixed-mode protein 
chromatography: principles, characteristics and design. Journal of biotechnology 2009, 
144 (1), 3-11. 
48. Sørensen, S.; Justesen, S. J.; Johnsen, A. H., Purification and characterization of 
osteopontin from human milk. Protein Expression and Purification 2003, 30 (2), 238-
245. 
49. Azuma, N.; Maeta, A.; Fukuchi, K.; Kanno, C., A rapid method for purifying 
osteopontin from bovine milk and interaction between osteopontin and other milk 
proteins. International Dairy Journal 2006, 16 (4), 370-378. 
50. Hwang, S.; Lopez, C. A.; Heck, D. E.; Gardner, C. R.; Laskin, D. L.; Laskin, J. 
D.; Denhardt, D. T., Osteopontin inhibits induction of nitric oxide synthase gene 
expression by inflammatory mediators in mouse kidney epithelial cells. Journal of 
Biological Chemistry 1994, 269 (1), 711-715. 
 77 
 
51. Xuan, J. W.; Hota, C.; Chambers, A. F., Recombinant GST‐human osteopontin 
fusion protein is functional in RGD‐dependent cell adhesion. Journal of cellular 
biochemistry 1994, 54 (2), 247-255. 
52. Rollo, E. E.; Laskin, D. L.; Denhardt, D. T., Osteopontin inhibits nitric oxide 
production and cytotoxicity by activated RAW264. 7 macrophages. Journal of leukocyte 
biology 1996, 60 (3), 397-404. 
53. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Analytical 
biochemistry 1976, 72 (1-2), 248-254. 
 
  
 78 
 
APPENDIX 
Dynamic binding capacity determination 
Dynamic binding capacity (DBC) is one of the most important parameter in 
chromatography process development, especially for the capture step. However, with the 
presence of a large variety and quantity of impurities, DBC could not be easily translated 
from batch adsorption data. Experimental determination of DBC were conducted by 
constant loading the feed material onto packed-bed column, sampling the flowthrough 
and plot a breakthrough curve. 
In the case of this study, both HEA HyperCel and Capto Q resins were capable of 
being the capture step for OPN purification from a separation power perspective. 
Therefore, DBC of the two resins could be the deciding factor of which resin serves 
better as the capture step for OPN purification. 
HEA HyperCel breakthrough curve 
Clarified lysate was loaded to pre-equilibrated PRC HEA HyperCel column (1 
ml) at 60 cm/h linear velocity and the flowthrough were collected in 2 ml fraction 
samples. 
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Supplementary Figure 1  Breakthrough Curve of OPN on HEA HyperCel  
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